Track market-moving stories before they get noisy

Key Takeaways Casey's posted 5.5% inside same-store sales growth, with inside margin reaching 42.4%.Prepared food and beverages drove momentum, with 6.6% same-store sales growth and a 59.5% margin.Casey's expects inside sales to rise 2-5% in fiscal 2027 while targeting at least 120 new stores. Casey’s General Stores, Inc. (CASY - Free Report) continues to benefit from solid momentum across its food and grocery categories, supporting the performance of its inside business. In the fourth quarter of fiscal 2026, inside same-store sales increased 5.5%, while inside margin reached 42.4%. The performance reflects continued strength across prepared food, dispensed beverages, grocery and general merchandise, highlighting the company’s differentiated in-store offering.

A key contributor to this momentum is the prepared food and dispensed beverage category. Same-store sales increased 6.6% in the quarter, with whole pizzas, appetizers and sides supporting performance. The category generated a 59.5% margin. Casey’s has continued to broaden its food platform through Thin Crust Pizza, limited-time pizza offerings, an expanded specialty pizza menu, a revamped hot sandwich lineup and new beverage platforms.

The expansion of chicken wings provides another avenue to strengthen the prepared food platform. Casey’s expanded its sauced wings program to nearly 850 stores by the end of fiscal 2026 and plans to extend the offering across the remainder of its store base over the next two fiscal years. Management views wings as an incremental food occasion, with customers who place standalone wings orders increasing their prepared food purchase frequency by 30%.

Grocery and general merchandise are supporting the inside business through favorable category mix. Fourth-quarter same-store sales increased 5.1%, while margin reached 35.7%. Energy drinks remained a strong area within nonalcoholic beverages, while the shift toward nicotine alternatives and Casey’s broader liquor assortment are expected to provide structural margin benefits.

Casey’s expects inside same-store sales to increase 2-5% in fiscal 2027, with inside margin above 42%. Management also expects EBITDA to increase 8-10% and plans to open at least 120 stores through a mix of acquisitions and new construction. Continued development of the prepared food platform and favorable grocery category mix should provide additional support for the company’s inside-store growth strategy.

Casey's Price Performance, Valuation & EstimatesShares of the company have surged 65.5% over the past year compared with the industry’s 65.9% growth.

Image Source: Zacks Investment Research

From a valuation standpoint, CASY is trading at a forward 12-month price-to-sales ratio of 1.49X, up from the industry average of 1.12X. It has a Value Score of B.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for Casey's fiscal 2027 earnings implies year-over-year growth of 10.2%, whereas the same for fiscal 2028 indicates an uptick of 11%. Estimates for fiscal 2027 and 2028 have been revised downward by 3 cents and 6 cents, respectively, in the past seven days.

Image Source: Zacks Investment Research

Casey's currently has a Zacks Rank #3 (Hold).

Key PicksWe have highlighted three better-ranked stocks in the retail space, namely Target Corporation (TGT - Free Report) , Macy's, Inc. (M - Free Report) and Dollar General Corporation (DG - Free Report) .

Target Corporation offers guests fashionable, differentiated merchandise and everyday essentials at discounted prices. It currently sports a Zacks Rank of 1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for Target’s current fiscal-year earnings and sales suggests growth of 37.7% and 4.6%, respectively, from the year-ago actuals. TGT delivered a trailing four-quarter average earnings surprise of 10.5%.

Macy's sells a wide range of merchandise, including men’s, women’s and children’s apparel and accessories, cosmetics, home furnishings and other consumer goods. The company carries a Zacks Rank #2 (Buy) at present.

The Zacks Consensus Estimate for Macy's current fiscal-year earnings and sales suggests decline of 4.3% and growth of 0.1%, respectively, from the year-ago actuals. Macy's delivered a trailing four-quarter average earnings surprise of 211%.

Dollar General is one of the largest discount retailers in the United States. The company carries a Zacks Rank #2 at present.

The Zacks Consensus Estimate for Dollar General’s current fiscal-year earnings and sales indicates growth of 7.6% and 3.9%, respectively, from the year-ago actuals. DG delivered a trailing four-quarter average earnings surprise of 21%.

BlackRock Inc. acquired a new position in shares of AMN Healthcare Services Inc (NYSE:AMN – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 6,643,401 shares of the company’s stock, valued at approximately $215,047,000. BlackRock Inc. owned 17.13% of AMN Healthcare Services as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of AMN. Summit Securities Group LLC acquired a new stake in shares of AMN Healthcare Services in the 4th quarter valued at approximately $32,000. Versant Capital Management Inc increased its position in AMN Healthcare Services by 41.8% during the 2nd quarter. Versant Capital Management Inc now owns 1,170 shares of the company’s stock worth $38,000 after purchasing an additional 345 shares in the last quarter. Johnson Financial Group Inc. bought a new position in AMN Healthcare Services in the 3rd quarter valued at approximately $63,000. Tower Research Capital LLC TRC lifted its stake in AMN Healthcare Services by 49.2% in the 2nd quarter. Tower Research Capital LLC TRC now owns 3,093 shares of the company’s stock valued at $64,000 after purchasing an additional 1,020 shares during the last quarter. Finally, Strs Ohio acquired a new stake in AMN Healthcare Services in the first quarter valued at approximately $95,000. 99.23% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets A number of research firms have weighed in on AMN. Weiss Ratings raised shares of AMN Healthcare Services from a “sell (d-)” rating to a “sell (d+)” rating in a research note on Tuesday, August 11th. Wall Street Zen cut AMN Healthcare Services from a “buy” rating to a “hold” rating in a research note on Tuesday. BMO Capital Markets raised their price objective on AMN Healthcare Services from $25.00 to $26.00 and gave the company an “outperform” rating in a report on Monday, May 11th. Truist Financial boosted their price objective on AMN Healthcare Services from $26.00 to $40.00 and gave the stock a “buy” rating in a research report on Wednesday, July 22nd. Finally, Citigroup reaffirmed an “outperform” rating on shares of AMN Healthcare Services in a report on Friday, August 14th. Four investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $31.43.

Check Out Our Latest Analysis on AMN AMN Healthcare Services Price Performance AMN stock opened at $35.07 on Friday. The company has a market capitalization of $1.36 billion, a P/E ratio of 13.09, a PEG ratio of 1.26 and a beta of 0.40. The company has a fifty day moving average price of $33.53 and a 200-day moving average price of $26.51. The company has a debt-to-equity ratio of 1.00, a quick ratio of 1.13 and a current ratio of 1.13. AMN Healthcare Services Inc has a 52-week low of $14.97 and a 52-week high of $37.22.

AMN Healthcare Services (NYSE:AMN – Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $0.77 EPS for the quarter, beating the consensus estimate of $0.19 by $0.58. AMN Healthcare Services had a return on equity of 19.92% and a net margin of 3.06%.The business had revenue of $673.24 million for the quarter, compared to analysts’ expectations of $628.39 million. During the same period in the prior year, the business posted $0.30 earnings per share. The firm’s revenue was up 2.3% on a year-over-year basis. As a group, equities analysts expect that AMN Healthcare Services Inc will post 3.1 EPS for the current year.

Insider Buying and Selling at AMN Healthcare Services In related news, Director Mark G. Foletta sold 3,681 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $31.07, for a total transaction of $114,368.67. Following the transaction, the director directly owned 17,917 shares of the company’s stock, valued at approximately $556,681.19. This represents a 17.04% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 1.07% of the company’s stock.

AMN Healthcare Services Company Profile (Free Report)

AMN Healthcare Services, Inc (NYSE: AMN) is a leading provider of healthcare workforce solutions in the United States. The company specializes in staffing and recruitment services for a broad range of clinical and allied health professionals, including travel nurses, permanent placement of nursing staff, locum tenens physicians, and allied health personnel. In addition to direct staffing, AMN Healthcare offers comprehensive workforce management solutions such as vendor management systems (VMS), recruitment process outsourcing (RPO), and compliance and credentialing services through its technology platforms.

Founded in 1985 as American Mobile Nurses, the company rebranded to AMN Healthcare in 2010 to reflect its expanding portfolio of services.

Featured Stories Five stocks we like better than AMN Healthcare Services Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape SEC Probe Puts Wall Street Leverage Risk Back in Focus A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?

Receive News & Ratings for AMN Healthcare Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMN Healthcare Services and related companies with MarketBeat.com's FREE daily email newsletter.

Key Takeaways LAMR benefits from resilient local sales, which grew for the 21st consecutive quarter in Q2 2026.LAMR raised 2026 AFFO guidance to $8.75-$8.90 as digital and programmatic revenues expanded.Lamar is pursuing digital conversions and acquisitions while supporting a dividend policy. Lamar Advertising Company (LAMR - Free Report) is one of the largest owners and operators of outdoor advertising structures in the United States. The company delivers advertising solutions to industries, including restaurants, retail, automotive, real estate, healthcare and gaming.

Analysts seem bullish on this Zacks Rank #2 (Buy) stock. The estimate revision trend for 2026 adjusted funds from operations (AFFO) per share indicates a favorable outlook, with estimates moving north over the past month.

Over the past six months, shares of Lamar have increased 8%, outperforming the industry’s 2.1% growth. Given its solid fundamentals and positive estimate revisions, the stock is likely to maintain its momentum in the quarters ahead.

Image Source: Zacks Investment Research

What Makes Lamar a Solid Choice?Diversification & Resilient Local Engine: Lamar benefits from a broad national footprint, a meaningful logo-sign business and a diversified advertiser base across multiple categories. In the second quarter of 2026, local and regional sales represented about 77% of billboard revenues and grew for the 21st consecutive quarter, while national and programmatic revenues increased nearly 16%. This diversified mix helps reduce reliance on any single demand source.

Lamar raised its 2026 AFFO per share guidance to $8.75-$8.90, providing support for continued cash-flow growth if current booking trends persist.

Digital Scale & Programmatic Monetization: Lamar’s continued expansion of its digital platform is supporting revenue growth and broadening advertiser demand. The company ended the second quarter of 2026 with 5,730 digital units, up 177 from year-end 2025. Digital billboard revenues increased 15.4% year over year and represented about one-third of billboard revenues, while same-board digital revenues rose 6.5%.

Programmatic revenues increased more than 50% during the second quarter and accounted for roughly 10% of digital billboard revenues. Lamar continues to deploy capital toward its digital footprint because same-board growth is outpacing the static base. Over time, further digital conversions and increased programmatic buying could improve the revenue-generating potential of Lamar’s existing billboard assets.

Structural Tailwinds, Defensible Leadership and Barriers: Out-of-home remains a cost-effective medium supported by digital adoption and advertiser demand for measurable exposure. Management said some advertising spend is shifting from local radio, print and network-affiliate television, while advertisers are also seeking alternatives to parts of digital media. Lamar’s scale and regulatory barriers support pricing because permitting and zoning constraints limit new supply.

Disciplined Growth Investments: Lamar continues to pursue growth through digital conversions, bolt-on acquisitions and purchases of easements beneath key billboard locations. Through June 30, 2026, the company had spent more than $100 million on nearly 30 billboard acquisitions as well as easement purchases, and management expects full-year cash spending on acquisitions and easements to exceed $200 million.

In August 2026, Lamar acquired the assets of AdSource Outdoor Advertising through what the company describes as the billboard industry’s second-ever UPREIT transaction. The acquisition added more than 230 billboard faces across Louisiana, including 30 digital displays, to Lamar’s portfolio.

At the end of the second quarter, liquidity was $720 million and investment capacity was well above $1 billion, giving Lamar room to pursue acquisitions. Full-year capital expenditure remains projected at about $186 million, including $65 million of maintenance CapEx.

Solid Dividend Payout: Lamar maintains shareholder-friendly dividend policy tied to taxable income and its REIT distribution requirements. The company paid $1.60 per share in each of the first two quarters of 2026. Following the second-quarter performance, management said it would recommend increasing the third-quarter dividend to $1.65 per share, subject to board approval.

Management also indicated that it would likely seek approval for a special dividend at year-end if current performance and expectations hold. This would be consistent with Lamar's stated policy of distributing 100% of its taxable income annually.

Other Stocks to ConsiderSome other top-ranked stocks from the broader REIT sector are American Tower (AMT - Free Report) and Host Hotels & Resorts (HST - Free Report) , each carrying a Zacks Rank #2 at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Zacks Consensus Estimate for AMT’s 2026 FFO per share is pinned at $11.07. This indicates year-over-year growth of 2.88%.

The Zacks Consensus Estimate for HST’s 2026 FFO per share is pegged at $2.17. This calls for a year-over-year increase of 4.83%.

Note: Anything related to earnings presented in this write-up represents funds from operations (FFO), a widely used metric to gauge the performance of REITs.

Results from the second 2026 core hole continue to reinforce the significance of mapped high-angle structures as controls on gold mineralization at the SSD Target

Gold mineralization is open in all directions, especially down-dip into promising structural and stratigraphic settings that have never been drill-tested

T2601 and T2602 confirmed the presence of a lamprophyre-filled fault corridor; igneous rocks are noteworthy for their association with gold mineralization in Carlin-type gold systems

Vancouver, British Columbia, August 25, 2026 – TheNewswire - Westward Gold Inc. (CSE: WG, OTCQB: WGLIF, FSE: IM50) (“Westward” or the “Company”) is pleased to announce assay results for the second core hole completed at the SSD Target (“SSD”), Toiyabe Hills Property, Lander County, NV (“Toiyabe Hills”, or the “Property”). T2601 and T2602 – drilled to total depths of 123 and 116 metres, respectively – were designed to 1) characterize the host rocks, hydrothermal alteration, and structure associated with gold mineralization at SSD, 2) verify the continuity of these features from their surface expression downward into the third dimension, 3) build upon the data gleaned from nearby trenching to further determine controls on gold mineralization (see Westward press release dated August 4, 2026), 4) apply these controls as a vector for upcoming deeper drilling and a tool for additional near-term SSD target development, and 5) modernize and upgrade previously-unconfirmed legacy data from the near-surface environment at SSD.

Key Takeaways:

T2602 intersected 34.9 metres of 2.91 g Au/t, including 4.1 metres of 16.15 g Au/t in silty limestone of the Wenban Formation; this broad zone of gold mineralization is characterized by pervasive decalcification, variable silicification, carbon, pyrite, variable clay alteration, and breccia associated with high-angle faults and penetrative shearing (see Figures 1 through 4 below). 

T2601 and T2602 have verified the presence of a lamprophyre-filled fault corridor, building upon prior observations of lamprophyre and quartz porphyry sills and dikes in and around the greater SSD Target area; these specific igneous rocks support the likelihood of a robust Carlin-type gold system on the Property. 

The gold intercepts in T2602 have reinforced the modeling of Fault-N and Fault-G as important controlling structures (originally identified through trenching and followed up on in hole T2601), with their hanging-wall zones demonstrating significant gold grades (see Figure 6 below). 

T2602 marks the first occurrence of orpiment logged in drill core to date – this bright yellow arsenic sulfide mineral typically forms as late-stage vein / fracture filling in Carlin-type systems, and is a key pathfinder mineral in early-stage gold exploration (see Figure 5 below). 

Elevated arsenic and antimony are associated with gold mineralization, providing further confirmation of a Carlin-type gold system. 

Figure 1 – T2602: Stratigraphy, Gold Grades, and Detailed Logging

Click Image To View Full Size

Figure 2 – SSD Target: 2026 Assay Results

Click Image To View Full Size

*UTM NAD83 Zone 11 Metres; Elevations: 2,309.2 m (T2601), 2,309.2 m (T2602).

Note: Gold intervals were calculated based on a 0.14 g Au/t cutoff grade. All gold intervals are presented as drill hole lengths; true thicknesses of mineralization are currently unknown and estimated at 50-70% of reported thicknesses. T2601 assay results were published on August 18, 2026. Refer to QA/QC statement below for additional details.

Mr. Steven Koehler, Westward’s Lead Technical Advisor, commented: “Relentless attention to detail – as I’m often reminded of by colleagues – is what ultimately drives success in Carlin-type gold exploration, and past discoveries have much to teach us in this regard. The data we’ve accumulated thus far at SSD (both legacy and current), and the exploration path it’s now leading us down, reminds me of a mid-1990’s program I led in the Carlin North region. The geological setting of these two areas is strikingly similar: near-surface gold mineralization in tandem with a zone of deeper, disseminated gold identified via sparse RC drilling. In the Carlin North example, initial trenching identified a 20-metre-wide gold-bearing fault cutting upper-plate rocks. As we continued to follow this structure down-dip, we drilled into a contiguous zone of upper-plate-hosted gold mineralization which evolved into the Crow Deposit. Deeper, framework-style drilling into favourable lower-plate carbonate rocks – along and adjacent to the fault – eventually resulted in the discovery and delineation of what is now the Pete Bajo underground mine.”

Mr. Koehler continued: “Geological themes and patterns tend to repeat in northern Nevada, and the many first-hand discovery lessons the technical team and I bring to the table will be invaluable as we advance SSD. T2602 has further confirmed that the SSD Target is a compelling opportunity, and we intend to aggressively explore the area with additional trenching, mapping, sampling and deeper drilling as near-term priorities.”

Figures 3 and 4 below display portions of the PQ-sized core that returned significant gold grades. The gold is predominantly hosted in silty limestone of the Devonian Wenban Formation, and the highest-grade samples are characterized by pervasive decalcification, secondary carbon flooding, elevated sooty pyrite, and breccia associated with penetrative shearing. Figure 5 below shows examples of logged orpiment in core, a significant pathfinder mineral in Carlin-type gold exploration; orpiment – similarly to realgar (both arsenic sulfide minerals) – commonly signals low-temperature hydrothermal activity linked to Carlin-style gold deposition.

Figure 3 – T2602 Select Core Photos (45.1 m – 49.7 m Depth)

Click Image To View Full Size

Figure 4 – T2602 Select Core Photos (49.7 m – 54.3 m Depth)

Click Image To View Full Size

Figure 5 – SSD Target: Examples of Orpiment Logged in T2602

Click Image To View Full Size

Note: Image on left from a depth of 88.7 metres, image on right from a depth of 90.1 metres.

SSD Target – Next Steps:

Gold mineralization encountered in T2601 and T2602 is open in all directions, most notably down-dip along controlling faults and into structural and stratigraphic settings that have never been tested. High-priority areas for upcoming drilling represent high-value targets in Nevada’s most favourable gold host rocks of the Wenban and underlying Roberts Mountains Formations.

Westward’s existing Plan of Operations with the U.S. Bureau of Land Management (“BLM”) over the SSD area is a significant strategic advantage, reducing permitting risk and enabling the Company to expand the scope of ground disturbance to accommodate additional roads, pads, and trenches in a timely manner. The season’s first reverse-circulation (“RC”) drill hole at SSD (T2603), was recently completed to a total depth of 396.2 metres, with the primary goal of testing the hanging-wall of Fault-G. Four deep RC holes are now planned to test down-dip extensions of gold mineralization in the hanging-wall of Fault-N (see Figure 6 below), along with additional step-out framework holes to the north and northeast; mapping, surface geochemistry, and geophysical surveys suggest the system may strengthen in these directions.

Figure 6 – SSD Target: Controlling Structures & Upcoming Drilling (Section View)

Click Image To View Full Size

Note: Section view looking northwest; 309-degree azimuth (LHS) and 316-degree azimuth (RHS), grades included on drill traces only shown if >0.5 g Au/t.

Hole details (all coordinates UTM NAD83 Zone 11 Metres):

T2601: Easting 522980, Northing 4432787, Elevation 2309.2, Azimuth 282, Inclination -70;

T2602: Easting 522980, Northing 4432790, Elevation 2309.2, Azimuth 311, Inclination -77;

T2603: Easting 522981.5, Northing 4432796.6, Elevation 2309.2, Azimuth 000, Inclination -90, TD 396.2 m;

SSD26-J: Easting 522245.1, Northing 4432710, Elevation 2190.6, Azimuth 000, Inclination -90, Estimated TD 914.4 m;

SSD26-K: Easting 522620, Northing 4432739, Elevation 2239.8, Azimuth 000, Inclination -90, Estimated TD 914.4 m;

SSD26-L: Easting 522721, Northing 4432552, Elevation 2205.1, Azimuth 000, Inclination -90, Estimated TD 914.4 m;

SSD26-M: Easting 522611, Northing 4432454, Elevation 2170.6, Azimuth 000, Inclination -90, Estimated TD 914.4 m.

Quality Assurance / Quality Control (“QA/QC”)

The Company implemented a best-practices QA/QC program during the drilling of core hole T2602. Drilling consisted of PQ-sized core from the collar to a total depth of 115.5 metres. All sampling was conducted under the supervision of the Company’s Vice President Exploration and/or members of its technical team, and the chain of custody from the Property to the sample preparation facility was continuously monitored. Samples were transported directly from the field to Modern Land and Development in Carlin, NV, where the individual sample intervals were cut in half and bagged for delivery.

Core samples were delivered to ALS Limited’s (“ALS”) preparation facility located in Elko, NV. Samples were dried at 100 degrees Celsius, crushed to 70% passing -2mm, Boyd rotary split off 250g, which was then pulverized to greater than 85% passing 75 microns. The resulting sample pulps were delivered to ALS’ laboratories at either 4977 Energy Way, Reno, NV, 89502 or 2103 Dollarton Hwy, North Vancouver, BC, V7H 0A7 for fire assay and multi-element assays.

Individual core samples for fire assay were selected at intervals ranging from 0.3m to 1.7m. Overall QA/QC frequency was set at a minimum of 15%, including standards, blanks, and three varieties of duplicates. Standards and blanks were sourced from Rocklabs of Aukland, New Zealand. Data verification of the analytical results included a statistical analysis of the standards, blanks and duplicates that must fall within specified ranges for acceptance. All standards, blanks and duplicates were checked and verified and are within these ranges. All core samples were analyzed for gold and 49 additional elements. Assays consisted of fire assay (Au-AA23) for gold on each individual sample. For multi-element geochemistry, composited intervals ranging between 5.8 metres to 7.8 metres were analyzed with four-acid analysis (ME-MS61m). Over-limit gold assays were determined using fire assay with a gravimetric finish (Au-GRA21) on a 30-gram split.

The significant gold zones were calculated using a weighted average of interval lengths and a cut-off grade of 0.14 g Au/t was employed, however internal dilution may include up to 6.7 metres of material below the cut-off. Drill-hole deviation for T2602 was measured by a gyroscopic down-hole survey completed by IDS of Elko, NV. The survey provides accurate down hole inclination and azimuth of the hole. Obtaining an accurate survey of the drill hole leads to a better contextual understanding of the core samples, and a more robust 3D geological model All gold intervals are presented as drill hole lengths; true thicknesses of mineralization are currently unknown and estimated at 50-70% of reported thicknesses. Refer to Westward Gold’s press release dated August 18, 2026, for additional T2601-specific QA/QC disclosure.

Qualified Person

The technical information contained in this news release was reviewed and approved by Robert Edie, Vice President Exploration of the Company, who is a Qualified Person under National Instrument 43-101 – Standards of Disclosure for Mineral Projects. Mr. Edie is a Certified Professional Geologist (CPG) through the American Institute of Professional Geologists (AIPG).

About Westward Gold

Westward Gold is a mineral exploration company focused on developing the Toiyabe Hills Project located in the Cortez Trend area of Lander County, Nevada, and the Coyote and Rossi Projects located along the Carlin Trend in Elko County, Nevada. From time to time, the Company may also evaluate the acquisition of other mineral exploration assets and opportunities.

For further information contact:

Andrew Nelson
Chief Financial Officer
Westward Gold Inc.
+1 (604) 828-7027

[email protected]

www.westwardgold.com

The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release. The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this news release.

This news release contains or incorporates by reference “forward-looking statements” and “forward-looking information” as defined under applicable Canadian securities legislation. All statements, other than statements of historical fact, which address events, results, outcomes, or developments that the Company expects to occur are, or may be deemed, to be, forward-looking statements. Forward-looking statements are generally, but not always, identified by the use of forward-looking terminology such as "expect", "believe", "anticipate", "intend", "estimate”, “potential”, “on track”, “forecast", "budget", “target”, “outlook”, “continue”, “plan” or variations of such words and phrases and similar expressions or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved or the negative connotation of such terms.

Such statements include, but may not be limited to, information as to strategy, plans or future financial or operating performance, such as the Company’s expansion plans, project timelines, expected drilling targets, and other statements that express management’s expectations or estimates of future plans and performance.

Forward-looking statements or information are subject to a variety of known and unknown risks, uncertainties and other factors that could cause actual events or results to differ from those reflected in the forward-looking statements or information, including, without limitation, the need for additional capital by the Company through financings, and the risk that such funds may not be raised; the speculative nature of exploration and the stages of the Company’s properties; the effect of changes in commodity prices; regulatory risks that development of the Company’s material properties will not be acceptable for social, environmental or other reasons, availability of equipment (including drills) and personnel to carry out work programs, that each stage of work will be completed within expected time frames, that current geological models and interpretations prove correct, the results of ongoing work programs may lead to a change of exploration priorities, and the efforts and abilities of the senior management team. This list is not exhaustive of the factors that may affect any of the Company’s forward-looking statements or information. These and other factors may cause the Company to change its exploration and work programs, not proceed with work programs, or change the timing or order of planned work programs. Additional risk factors and details with respect to risk factors that may affect the Company’s ability to achieve the expectations set forth in the forward-looking statements contained in this news release are set out in the Company’s latest management discussion and analysis under “Risks and Uncertainties”, which is available under the Company’s SEDAR+ profile at www.sedarplus.ca. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated, described or intended. Accordingly, readers should not place undue reliance on forward-looking statements or information. The Company’s forward-looking statements and information are based on the assumptions, beliefs, expectations, and opinions of management as of the date of this press release, and other than as required by applicable securities laws, the Company does not assume any obligation to update forward-looking statements and information if circumstances or management’s assumptions, beliefs, expectations or opinions should change, or changes in any other events affecting such statements or information.

It has been about a month since the last earnings report for Vulcan Materials (VMC - Free Report) . Shares have added about 1% in that time frame, underperforming the S&P 500.

Will the recent positive trend continue leading up to its next earnings release, or is Vulcan due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its latest earnings report in order to get a better handle on the important drivers.

Vulcan Materials Q2 Earnings & Revenues Beat EstimatesVulcan posted solid second-quarter 2026 results, with adjusted earnings and total revenues beating the Zacks Consensus Estimate and increasing year over year.

The quarter’s results reflect aggregates volume and pricing growth, commercial discipline and operating efficiencies. However, significant energy-related inflation and disruptive weather partly offset these benefits. Aggregates cash gross profit per ton increased to $12.02 from $11.88 in the year-ago quarter.

VMC's Q2 Earnings & RevenuesVMC reported adjusted earnings of $2.59 per share in the second quarter, beating the Zacks Consensus Estimate of $2.50 by 3.6%. The figure increased 5.7% from the year-ago quarter’s adjusted earnings of $2.45 per share.

Quarterly revenues were $2.16 billion, up 2.5% year over year and slightly ahead of the consensus mark. Aggregates shipments increased 1% to 59.9 million tons, supported by healthy public construction activity and large projects despite weather-related disruptions in certain markets.

VMC Delivers Resilient ProfitabilityProfitability remained resilient despite elevated energy costs. Gross profit was $625.5 million compared with $625.2 million a year ago. Operating earnings declined 3.3% year over year to $455.5 million. Net earnings attributable to Vulcan increased to $323.4 million from $320.9 million in the prior-year quarter.

Adjusted EBITDA decreased 0.9% to $654 million, and the adjusted EBITDA margin narrowed to 30.3% from 31.4%. Approximately $40 million of energy-related inflation tied to higher oil prices weighed on earnings, partly offsetting benefits from pricing and operating execution.

Vulcan Tightens Cost Structure as SAG LeveragesBelow-the-line discipline continued to support results. Selling, administrative and general (SA&G) expenses were $141.3 million, down from $144.5 million in the prior-year quarter. SA&G, as a percentage of revenues, improved year over year to 6.6% from 6.9%, reflecting continued leverage of the company's overhead cost structure.

The company recorded an $11.3 million loss on the sale of property, plant and equipment and businesses versus a $1.2 million gain a year ago. Other operating expense, net, increased to $17.4 million from $10.9 million, partly offsetting the benefits of stronger commercial execution.

Vulcan's Aggregates Engine Drives GrowthThe Aggregates segment again did the heavy lifting. Segment sales increased 6.9% year over year to $1.76 billion, while segment gross profit climbed to $567.3 million from $559.5 million. Cash gross profit increased to $720.1 million from $703.8 million.

Freight-adjusted sales price improved to $22.97 per ton from $22.11 year over year. On a mix-adjusted basis, pricing increased 5%, reflecting widespread pricing gains across the company's footprint. Cash gross profit per ton rose to $12.02 from $11.88.

Freight-adjusted revenues advanced to approximately $1.38 billion from $1.31 billion, highlighting continued pricing strength. At the same time, freight-adjusted cash cost of sales per ton increased 7% to $10.95 from $10.23, primarily due to higher diesel fuel costs. Excluding diesel inflation, unit cash costs increased 3%, supported by disciplined cost management and improved plant efficiencies. Aggregates shipments increased 1% to 59.9 million tons despite significant rainfall in Texas and certain Southeastern markets.

VMC's Asphalt and Concrete Reflect Portfolio ChangesPerformance in the downstream businesses reflected weather-related disruptions and recent portfolio actions. Asphalt segment revenues declined to $330 million from $368.7 million, while gross profit decreased to $49.8 million from $57.2 million. Nevertheless, the asphalt gross profit margin remained strong at 15%.

Operationally, asphalt mix shipments declined to 3.4 million tons from 3.9 million tons, while the average selling price improved to $85.74 per ton from $81.26. The prior-year quarter included the Houston asphalt and construction business, which was divested during the fourth quarter of 2025.

Concrete segment revenues declined to $186.8 million from $220.5 million, while gross profit was essentially flat at $8.4 million compared with $8.5 million a year ago. Ready-mixed concrete shipments decreased to 1 million cubic yards from 1.2 million cubic yards, while the average selling price increased to $189.94 from $186.52. Results reflected only two months of contributions from the California ready-mixed concrete business before its divestiture in early June.

Vulcan's Liquidity & Capital Return HighlightsLiquidity remained healthy at quarter-end, with cash and cash equivalents of $194.2 million. The company carried $400 million of current maturities of long-term debt and $3.96 billion of long-term debt. Total debt to trailing-12-month adjusted EBITDA stood at 1.9x, below management's targeted range of 2x to 2.5x.

VMC invested $176 million in maintenance and growth projects during the quarter. The company also returned $318 million to its shareholders through $250 million of share repurchases and $68 million of dividends.

During the quarter, Vulcan completed the divestiture of its California ready-mixed concrete operations. The company also acquired a quarry in southern Colorado and a rail yard in Dallas-Fort Worth, further strengthening its aggregates-led growth strategy.

VMC Reaffirms 2026 OutlookManagement reiterated its full-year adjusted EBITDA outlook of $2.4-$2.6 billion. The company expects continued aggregates price growth, supported by healthy public construction activity, large infrastructure projects and disciplined commercial execution. Vulcan also expects its ongoing focus on cost management, operating efficiencies and aggregates unit profitability to support earnings growth and cash generation throughout the remainder of 2026.

How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a downward trend in fresh estimates.

VGM ScoresCurrently, Vulcan has a average Growth Score of C, though it is lagging a lot on the Momentum Score front with an F. Charting a somewhat similar path, the stock has a grade of D on the value side, putting it in the bottom 40% for value investors.

Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.

OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Vulcan has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.

This Expensive Chip Stock Is Up 140%, Analysts Say It's Still a BuyLattice Semiconductor NASDAQ: LSCC CEO Ford Tamer and AMI Business Unit leader Sanjoy Maity outlined how the companies’ combination is intended to address growing management, control and security demands across AI data centers and physical AI systems.

Speaking at The Six Five Summit 2026, Tamer described Lattice as a provider of low-power programmable devices used alongside processors, networking equipment and sensors. The company’s small and mid-range FPGAs support functions including booting, power sequencing, security management, control, bridging, I/O expansion, sensor fusion and data processing, he said.

Get Lattice Semiconductor alerts:

3 AI Names With Big Buybacks: GEV, PSTG, and LSCC Signal ConfidenceAMI, which Maity said has developed foundational firmware for four decades, provides firmware used to boot, manage and secure AI data center infrastructure. Its offerings also include telemetry, monitoring, error correction and a “single pane of glass” view intended to help administrators oversee complex data center environments.

Combination targets faster deployment Tamer said the companies have known each other for six years and serve similar customers, including hyperscalers, neocloud providers, server and networking OEMs, and silicon and systems partners. He characterized the businesses as complementary because Lattice operates close to hardware and sensors, while AMI provides low-level firmware for managing and securing those components.

Lattice Semiconductor’s Market Reset Is Over: The Rebound Begins“Together, we believe we’re going to provide secure management control solution, a turnkey, and speed up our customers’ time to market,” Tamer said.

Maity said the combined organization aims to provide pre-validated solutions so customers can spend less time addressing integration issues and focus more on their own intellectual property and business development. He said the approach could reduce integration costs and accelerate product launches.

AI infrastructure is becoming more complex Tamer said AI infrastructure has undergone a rapid expansion in recent years, with 2025 centered on training workloads and 2026 seeing a greater shift toward inference and agentic AI. He said the shift has increased demand not only for GPUs but also for CPUs, storage and networking infrastructure.

He also cited changes in networking architectures, liquid cooling and increased sensor deployment. According to Tamer, the number of sensors in a server has grown to as many as 1,200, monitoring functions ranging from fans and cooling distribution units to optical interconnects.

That expansion has increased the use of low-power FPGAs from tens of devices per rack to hundreds of devices per rack, he said. Lattice’s devices are positioned near sensors and hardware components to provide deterministic, low-latency connectivity and parallel processing.

Data center infrastructure is becoming more disaggregated across compute, power and cooling, networking, and storage. Systems are becoming more heterogeneous, incorporating CPUs, GPUs, NPUs, Arm-based processors and RISC-V architectures. Operators need broader rack-, pod- and data-center-level management capabilities. Maity said scalability, security and sustainability are major industry challenges. AMI uses a modular firmware approach based on open-source technology that can support multiple architectures, board management controllers and companion chips using a single version of code, he said.

Security and physical AI opportunities Tamer highlighted security as a core application for programmable logic, particularly as requirements evolve around post-quantum cryptography. He said FPGAs can be updated in the field as security algorithms change, unlike fixed-function ASICs.

In physical AI, Tamer said Lattice works with NVIDIA on sensor-fusion and preprocessing functions associated with NVIDIA’s Holoscan platform. Lattice’s devices can process data from sensors and provide metadata to NVIDIA Thor and Orin systems, he said.

Looking further ahead, Tamer said disaggregated infrastructure, telemetry and automation could support more self-diagnostic and self-healing operations. He cited the potential need for such capabilities in future space-based data centers, where direct human servicing would be more difficult.

Revenue targets Tamer said the companies are focused in the near term on adding resources, meeting customer commitments and bringing combined solutions to market more quickly. Longer term, he said the goal is to become a leader in secure management and control for data center AI and physical AI.

Financially, Tamer said the company had guided at its most recent earnings call to a midpoint third-quarter revenue run rate of $1 billion for the combined businesses. He said it expects to exit the year at approximately a $1.2 billion run rate and has an aspirational target of reaching a $3 billion run rate by the end of 2030.

Tamer said Lattice generated $520 million in revenue in 2025 and that reaching the 2030 target would require annual revenue growth of slightly more than 25%.

About Lattice Semiconductor (NASDAQ:LSCC)Lattice Semiconductor Corporation is a U.S.-based semiconductor company specializing in low-power, small-footprint programmable logic devices. The company's product portfolio centers on field-programmable gate arrays (FPGAs), programmable logic devices (PLDs) and related intellectual property cores that enable customers to implement custom digital functions in applications where energy efficiency and compact size are critical. Lattice's solutions are widely used to accelerate edge computing, support video and sensor interfaces, and provide flexible I/O connectivity across a variety of end markets.

The company offers a range of FPGA families, including the iCE40 series for ultra-low power mobile and consumer applications, the MachXO series for embedded control and security, and the ECP5 series for midrange performance in communications, industrial automation and automotive domains.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Lattice Semiconductor Right Now?Before you consider Lattice Semiconductor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lattice Semiconductor wasn't on the list.

While Lattice Semiconductor currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

A month has gone by since the last earnings report for Tetra Tech (TTEK - Free Report) . Shares have added about 12.9% in that time frame, outperforming the S&P 500.

Will the recent positive trend continue leading up to its next earnings release, or is Tetra due for a pullback? Well, first let's take a quick look at its latest earnings report in order to get a better handle on the recent catalysts for Tetra Tech, Inc. before we dive into how investors and analysts have reacted as of late.

Tetra Tech Q3 Earnings Beat Estimates on Core Market GrowthTetra Tech posted third-quarter fiscal 2026 adjusted earnings of 42 cents per share, down 2.3% year over year but ahead of the Zacks Consensus Estimate of 40 cents by 5%.

Net revenues were $1.11 billion, down 3.9% year over year, but topped the consensus mark of $1.08 billion by 2.8%. Backlog ended the quarter at $4.49 billion, up 4.9% sequentially, supported by new wins across water infrastructure, defense and digital automation markets.

On a GAAP basis, Tetra Tech reported revenues of $1.31 billion compared with $1.37 billion in the year-ago quarter.

Tetra Tech Benefited From CIG Growth Offset by GSGRevenues from U.S. federal customers, accounting for 20% of the quarter’s net revenues, increased 12% year over year, excluding USAID, Department of State and episodic disaster-response activities. Growth was supported by higher activity with the Navy and U.S. Army Corps of Engineers. U.S. commercial revenues, representing 20% of the total, rose 1% as gains in power transmission offset lower renewable-energy activity.

U.S. state and local revenues, accounting for 13% of net revenues, increased 5% year over year, driven by strength in municipal water treatment, partly offset by lower flood-protection work. International revenues, representing 47% of the total, advanced 12% on growth in U.K. water and digital water automation programs.

Tetra Tech reports revenues under the segments discussed below:The Commercial/International Services Group delivered net revenues of $634.2 million, up 9.3% year over year. Government Services Group net revenues were $474.3 million, down 17.2% from the prior-year quarter on a reported basis. Excluding USAID, Department of State and episodic disaster-response activities, GSG net revenues increased 7%, reflecting strength in water infrastructure and defense programs.

Margin ProfileThe company continued to manage its costs while maintaining capacity for growth investments. In the fiscal third quarter, Tetra Tech’s subcontractor costs totaled $200 million, down 7.8% from the year-ago quarter. Other costs of revenues (adjusted) were $865.4 million, down 4% from the third quarter of fiscal 2025. Selling, general and administrative expenses (adjusted) declined 1.6% year over year to $85.2 million.

Adjusted operating income decreased 4.2% year over year to $158 million, while the adjusted operating margin remained unchanged at 14.3%.

Tetra Tech’s Balance Sheet and Cash FlowWhile exiting the fiscal third quarter, Tetra Tech had cash and cash equivalents of $230.8 million compared with $167.5 million recorded at the end of fiscal 2025. Long-term debt was $801.1 million compared with $763.4 million at fiscal 2025-end.

In the first nine months of fiscal 2026, Tetra Tech generated net cash of $466.6 million from operating activities compared with $356.8 million in the prior-year period. Capital expenditures were $14 million, up 11.5% year over year. Its proceeds from borrowings totaled $245 million, while repayments on long-term debt were $210 million.

Shareholder-Friendly PoliciesTetra Tech distributed dividends totaling $52.5 million in the first nine months of fiscal 2026, up from $48 million in the prior-year period. The company also repurchased shares worth $202 million compared with $200 million in the first nine months of fiscal 2025.

Fiscal 2026 OutlookFor fiscal 2026 (ending September 2026), Tetra Tech expects net revenues in the range of $4.315-$4.365 billion. At the midpoint, the outlook implies 8% year-over-year growth after excluding USAID, Department of State and episodic disaster-response activities.

Adjusted earnings are projected in the range of $1.56-$1.59 per share. The company expects adjusted EBITDA margin to expand 70 basis points year over year.

For the fiscal fourth quarter, management forecasts net revenues of $1.12-$1.17 billion. Adjusted earnings are expected in the range of 45-48 cents per share.

How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a upward trend in estimates revision.

VGM ScoresCurrently, Tetra has a average Growth Score of C, though it is lagging a lot on the Momentum Score front with an F. However, the stock has a score of C on the value side, putting it in the middle 20% for this investment strategy.

Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.

OutlookEstimates have been trending upward for the stock, and the magnitude of this revision looks promising. It comes with little surprise Tetra has a Zacks Rank #2 (Buy). We expect an above average return from the stock in the next few months.

Elastic ESTC is experiencing a surge following a robust Q1 performance, exceeding expectations for Q2 guidance and raising its FY27 outlook. This reflects improved sales execution leading to faster growth. Investors are encouraged by strong forward-demand indicators, record additions of large customers, increasing adoption of AI, and a new $500 million share repurchase authorization, despite net expansion metrics not yet showing improvement.

Sales-led subscription revenue grew by 18% to $399 million, up from 16% constant-currency growth in Q4. The current Remaining Performance Obligations (cRPO) rose 21% to $1.2 billion, while total RPO increased by 27% to $1.9 billion, indicating a trend towards larger, longer-term customer commitments to ESTC’s platform. ESTC welcomed over 80 new customers spending more than $100,000 annually, marking the largest quarterly increase and bringing the total to over 1,800. This group now accounts for 90% of sales-led subscription revenue. Notably, over 670 of these customers are utilizing ESTC's AI solutions, increasing AI penetration from around 21% last year to 37%, with AI users expanding slightly faster than non-AI customers. For Q2, ESTC anticipates a non-GAAP EPS of $0.80-$0.82 and revenue of $486-$487 million, slightly above FactSet consensus. The FY27 revenue guidance has been raised to $1.998-$2.010 billion, with sales-led subscription revenue projected between $1.682-$1.694 billion and adjusted EPS between $3.29-$3.37, driven by a stronger pipeline and improved sales productivity. Despite a slight decline in Net Expansion Rate (NER) to 111% from 112%, indicating that increased bookings and AI adoption have yet to enhance overall customer expansion, ESTC expects growth in total and sales-led subscriptions to accelerate in the second half of the year. The company aims for Q4 to deliver the fastest growth of the year while maintaining a 19.4% non-GAAP operating margin and a 21.5% adjusted free cash flow margin for FY27. In Q1, ESTC repurchased approximately $40 million in shares and has utilized $380 million of its initial $500 million repurchase program. The newly authorized $500 million indicates confidence in cash generation and expands future repurchase capacity, although the timing of purchases remains unspecified.The significant takeaway is that ESTC's quarterly success is complemented by improving forward indicators and a heightened annual outlook, rather than solely relying on expense management. The growth in cRPO and RPO, record enterprise additions, and enhanced AI adoption bolster management's expectations for acceleration in the second half. However, the decline in NER to 111% indicates that recent activity has not yet translated into overall customer expansion. ESTC must now convert long-term commitments and AI adoption into sustained consumption while maintaining its improving margins. Key upcoming focuses include Q2 execution, stabilization of NER, continued growth of high-spending customers, and progress towards achieving over 20% sales-led subscription growth in the medium term.

This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Disclosures I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.

Algert Global LLC lowered its holdings in ABM Industries Incorporated (NYSE:ABM – Free Report) by 7.5% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 197,440 shares of the business services provider’s stock after selling 15,940 shares during the period. Algert Global LLC owned approximately 0.34% of ABM Industries worth $8,735,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in ABM. First Eagle Investment Management LLC bought a new stake in ABM Industries during the fourth quarter valued at about $7,623,000. Quantinno Capital Management LP increased its holdings in shares of ABM Industries by 86.3% during the 1st quarter. Quantinno Capital Management LP now owns 54,790 shares of the business services provider’s stock worth $2,111,000 after purchasing an additional 25,388 shares during the period. Louisiana State Employees Retirement System acquired a new position in shares of ABM Industries during the first quarter valued at about $1,002,000. Pacer Advisors Inc. bought a new stake in shares of ABM Industries in the first quarter valued at about $12,739,000. Finally, BlackRock Inc. bought a new position in ABM Industries in the second quarter worth $410,948,000. 91.62% of the stock is currently owned by institutional investors and hedge funds.

ABM Industries Trading Up 2.3% NYSE ABM opened at $47.66 on Thursday. The stock has a 50-day simple moving average of $46.60 and a 200 day simple moving average of $43.06. The company has a market capitalization of $2.79 billion, a PE ratio of 18.33, a P/E/G ratio of 1.22 and a beta of 0.69. ABM Industries Incorporated has a 12 month low of $36.96 and a 12 month high of $50.12. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 1.04.

ABM Industries (NYSE:ABM – Get Free Report) last issued its quarterly earnings data on Friday, June 5th. The business services provider reported $0.90 EPS for the quarter, missing analysts’ consensus estimates of $0.92 by ($0.02). ABM Industries had a return on equity of 11.84% and a net margin of 1.75%.The company had revenue of $2.29 billion for the quarter, compared to analyst estimates of $2.21 billion. During the same quarter in the previous year, the business earned $0.86 earnings per share. The company’s revenue was up 8.4% on a year-over-year basis. ABM Industries has set its FY 2026 guidance at 3.850-4.150 EPS. Research analysts forecast that ABM Industries Incorporated will post 3.97 EPS for the current year. ABM Industries Dividend Announcement The firm also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 2nd were issued a $0.29 dividend. The ex-dividend date of this dividend was Thursday, July 2nd. This represents a $1.16 dividend on an annualized basis and a yield of 2.4%. ABM Industries’s payout ratio is currently 44.62%.

Insiders Place Their Bets In related news, CEO Scott B. Salmirs sold 50,000 shares of the stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $46.34, for a total transaction of $2,317,000.00. Following the sale, the chief executive officer owned 395,285 shares in the company, valued at approximately $18,317,506.90. This trade represents a 11.23% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.90% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades Several brokerages have recently weighed in on ABM. Robert W. Baird lifted their target price on shares of ABM Industries from $45.00 to $48.00 and gave the company a “neutral” rating in a research report on Monday, June 8th. Weiss Ratings raised ABM Industries from a “hold (c)” rating to a “hold (c+)” rating in a report on Tuesday, August 11th. One investment analyst has rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $47.00.

View Our Latest Report on ABM Industries

ABM Industries Company Profile (Free Report)

ABM Industries Incorporated is a leading provider of integrated facility services, offering a comprehensive suite of solutions designed to support the operation, maintenance and enhancement of commercial properties. The company’s core services include janitorial and custodial maintenance, HVAC and mechanical systems support, electrical and lighting solutions, and energy optimization. Additional offerings span parking management, security services, landscaping, and specialized support such as technical solutions and sustainability consulting.

Serving a diverse range of markets, ABM caters to clients in commercial real estate, aviation, healthcare, manufacturing, education, government entities, and technology campuses.

Recommended Stories Five stocks we like better than ABM Industries Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise Alcoa’s Gallium Project Opens a New Door Beyond Aluminum Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech Can Tesla’s Flying Roadster Distract From Its Real Risks?

Receive News & Ratings for ABM Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ABM Industries and related companies with MarketBeat.com's FREE daily email newsletter.

Key Takeaways The Hanover's net premiums written increased 4.4% in Q2 2026, supported by disciplined pricing.Personal Lines' combined ratio improved 290 bps to 81.9%, driven by better homeowners and auto results.Net investment income rose 13.4% to $119.6 million, aided by higher earned yields and operating cash flows. The Hanover Insurance Group, Inc. (THG - Free Report) is trading at 2.16X trailing 12-month book value, well above the industry's average of 1.43X. However, the valuation remains far below broader market yardsticks, including the Zacks Finance sector at 4.43x and the S&P 500 at 7.21x. The stock currently carries a Value Score of A.

The premium valuation reflects investors' willingness to pay more for THG's capital. The higher multiple raises the question of whether the company's strong underwriting performance, sustained profitability and disciplined capital management are sufficient to justify it.

Image Source: Zacks Investment Research

Shares of some other insurers, like Arch Capital Group Ltd. (ACGL - Free Report) , American Financial Group, Inc. (AFG - Free Report) and Mercury General Corporation (MCY - Free Report) , are also trading at a premium to the industry average.

THG’s Strong Return on EquityReturn on equity (ROE) for the trailing 12 months was 21.7%, significantly above the industry's 7.5%. Moreover, ROE has remained above 20% over the past three to five years, reflecting the company's consistent ability to generate returns from shareholders' funds.

THG’s Price PerformanceShares of Hanover Insurance have gained 31.4% in the past year compared with the industry’s growth of 2%. Disciplined underwriting, effective pricing, Specialty expansion and higher investment income have supported the stock's performance.

Shares of other insurers like ACGL, AFG and MCY have gained 11.3%, 7.6% and 36.5%, respectively, over the past year.

1-Year Price Performance: THG, ACGL, AFG, MCY & Industry

Image Source: Zacks Investment Research

THG’s Growth ProjectionThe Zacks Consensus Estimate for THG’s 2026 earnings per share (EPS) indicates a year-over-year increase of 5.7%. The consensus estimate for revenues is pegged at $6.95 billion, implying a year-over-year increase of 4.6%.

The consensus estimate for 2027 revenues indicates an increase of 4.5%, while EPS decreased 0.6%, from the corresponding 2026 estimates.

Optimistic Analyst Sentiment on THGFive analysts covering the stock have raised earnings estimates for 2026 and 2027, respectively, with no downward revision over the past 30 days. The consensus estimate for 2026 and 2027 earnings has moved 9.7% and 6.7% north, respectively, over the same time period.

Image Source: Zacks Investment Research

Key Points to Note for THGThe Hanover's pricing continues to exceed loss-cost trends across both Commercial and Personal Lines, supporting durable underwriting margins despite softening property market conditions. Management expects pricing to remain favorable in 2026, particularly in Commercial and Personal auto liability, while commercial-line retention remains stable. Net premiums written increased 4.4% in the second quarter of 2026, reflecting the company's disciplined approach to profitable growth. This continued pricing discipline should help sustain underwriting margins even if premium growth remains measured.

Specialty continued to deliver attractive underwriting margins in the second quarter of 2026. Management expects overall Specialty growth to ramp up, with marine expected to return to upper single-digit growth for the remainder of 2026. Robust underwriting performance across property, management liability, surety, marine and E&S continues to support earnings. Management remains willing to sacrifice near-term premium growth to preserve long-term profitability.

Personal Lines is benefiting from earned pricing and margin initiatives. The combined ratio improved 290 basis points to 81.9% in the second quarter of 2026, driven by better homeowners and auto results. Net premiums written rose 2.6%, while higher pricing, retention and a growing Prestige mix supported portfolio quality. As geographic diversification and full-account strategies scale, the segment has room to contribute steadier earnings and support consolidated results through the cycle.

Net investment income increased 13.4% year over year to $119.6 million in the second quarter of 2026, driven by operating cash flows and higher earned yields. The portfolio’s pretax earned yield increased to 4.28% from 4.11%, while the fixed-maturity yield improved to 4.45% from 4.24%. The improvement in yields has strengthened the company's investment returns and provided an additional source of earnings growth beyond underwriting operations.

Ongoing investments in AI and digital capabilities are enhancing underwriting efficiency, risk selection, claims handling and quoting speed. AI-enabled underwriting, automated risk scoring and claims triage are further improving operational execution.

THG continues to generate strong capital and remains committed to enhancing shareholder value through a balanced capital deployment strategy that includes regular dividend payments and ongoing share repurchases. Book value per share increased 3.5% sequentially to $105.40. It has about $660 million under the company’s authorization.

ConclusionTHG is positioned to benefit from pricing discipline, Specialty strength, improving Personal Lines performance, ongoing investments in artificial intelligence and higher investment income. Its sustained ROE above 20%, solid underwriting execution and disciplined capital deployment provide support for its premium valuation.

A VGM Score of B instils confidence. The time appears right for potential investors to bet on this Zacks Rank #1 (Strong Buy) insurer. You can see the complete list of today’s Zacks #1 Rank stocks here.

NEW YORK, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of AECOM (“AECOM” or the “Company”) (NYSE: ACM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

The investigation concerns whether AECOM and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On May 11, 2026, AECOM announced its second quarter fiscal 2026 results, including, in relevant part, that quarterly operating cash flow was $4 million, down 98% year over year, and adjusted free cash flow which swung to negative $27 million. In the accompanying earnings call, the Company’s Chief Financial Officer, Gaurav Kapoor, revealed that “longer-than-anticipated claim resolution on certain projects” among other things, impacted the quarter. Kapoor further stated these were “projects we bid in fiscal year 2019 and 2020, two projects” for two clients, and that “individual claims for these two clients have gone through the resolution process. And we’ve been successful on each one of them. But it’s just been very slow and dragged out on the resolution process. That is what has surprised us as to how long the process has taken.” Then, on May 12, 2026, AECOM filed its quarterly report on Form 10-Q, which showed that significant claims recorded in contract assets and other non-current assets were approximately $680 million as of March 31, 2026, compared with approximately $400 million as of September 30, 2025. 

Following these disclosures, AECOM’s stock price fell $9.55 per share, or 12%, to close at $69.95 per share on May 12, 2026. 

Then, on August 11, 2026, AECOM reported weaker-than-expected results for the third quarter of 2026, which were impacted by a $337 million pre-tax loss related to the delayed completion of a construction management project. 

On this news, AECOM’s stock price fell $6.25 per share, or 8.53%, to close at $67.05 per share on August 11, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980

Bamco Inc. NY purchased a new stake in shares of LPL Financial Holdings Inc. (NASDAQ:LPLA – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 114,224 shares of the financial services provider’s stock, valued at approximately $32,175,000. Bamco Inc. NY owned 0.15% of LPL Financial at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the stock. Osterweis Capital Management Inc. purchased a new position in LPL Financial in the second quarter valued at about $26,000. Clearstead Advisors LLC lifted its stake in shares of LPL Financial by 3,650.0% in the fourth quarter. Clearstead Advisors LLC now owns 75 shares of the financial services provider’s stock worth $27,000 after buying an additional 73 shares during the last quarter. Core Wealth Advisors LLC bought a new position in LPL Financial in the 4th quarter worth $36,000. Physician Wealth Advisors Inc. raised its holdings in LPL Financial by 580.0% in the 1st quarter. Physician Wealth Advisors Inc. now owns 136 shares of the financial services provider’s stock worth $41,000 after acquiring an additional 116 shares during the period. Finally, Pinpoint Asset Management Singapore Pte. Ltd. acquired a new position in LPL Financial during the 4th quarter worth $50,000. Institutional investors and hedge funds own 95.66% of the company’s stock.

LPL Financial Stock Performance LPL Financial stock opened at $360.24 on Thursday. LPL Financial Holdings Inc. has a 12-month low of $260.15 and a 12-month high of $400.16. The stock has a 50-day simple moving average of $330.25 and a 200 day simple moving average of $315.00. The stock has a market capitalization of $28.37 billion, a price-to-earnings ratio of 28.73, a P/E/G ratio of 0.61 and a beta of 0.48. The company has a quick ratio of 2.39, a current ratio of 2.39 and a debt-to-equity ratio of 1.30.

LPL Financial (NASDAQ:LPLA – Get Free Report) last released its earnings results on Thursday, July 30th. The financial services provider reported $5.84 EPS for the quarter, beating the consensus estimate of $5.39 by $0.45. LPL Financial had a return on equity of 32.20% and a net margin of 5.13%.The company had revenue of $5.19 billion during the quarter, compared to analysts’ expectations of $5.04 billion. During the same period last year, the firm earned $4.51 EPS. The business’s revenue for the quarter was up 35.2% on a year-over-year basis. On average, research analysts anticipate that LPL Financial Holdings Inc. will post 24.09 earnings per share for the current fiscal year. LPL Financial Dividend Announcement The firm also recently declared a quarterly dividend, which will be paid on Friday, August 28th. Shareholders of record on Friday, August 14th will be issued a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 0.3%. The ex-dividend date is Friday, August 14th. LPL Financial’s dividend payout ratio is 9.57%.

Analyst Upgrades and Downgrades A number of research firms have issued reports on LPLA. William Blair reaffirmed an “outperform” rating on shares of LPL Financial in a report on Thursday, June 4th. Barclays increased their price objective on LPL Financial from $394.00 to $401.00 and gave the company an “overweight” rating in a research report on Friday, July 31st. Weiss Ratings restated a “hold (c)” rating on shares of LPL Financial in a research note on Friday, July 24th. UBS Group dropped their target price on shares of LPL Financial from $395.00 to $391.00 and set a “buy” rating on the stock in a research report on Wednesday, July 8th. Finally, Morgan Stanley lifted their target price on LPL Financial from $374.00 to $387.00 and gave the stock an “overweight” rating in a research report on Friday, July 10th. Twelve research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, LPL Financial currently has an average rating of “Moderate Buy” and a consensus target price of $406.69.

Get Our Latest Stock Report on LPLA

Insiders Place Their Bets In other news, Director Greg Gates sold 4,119 shares of LPL Financial stock in a transaction dated Thursday, August 20th. The stock was sold at an average price of $355.38, for a total transaction of $1,463,810.22. Following the transaction, the director owned 23,602 shares in the company, valued at $8,387,678.76. The trade was a 14.86% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Aneri Jambusaria sold 308 shares of the company’s stock in a transaction that occurred on Wednesday, June 17th. The shares were sold at an average price of $306.00, for a total transaction of $94,248.00. Following the completion of the transaction, the director owned 6,415 shares of the company’s stock, valued at $1,962,990. This trade represents a 4.58% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 5,427 shares of company stock worth $1,910,778 over the last ninety days. 0.60% of the stock is currently owned by corporate insiders.

LPL Financial Company Profile (Free Report)

LPL Financial (NASDAQ: LPLA) is a U.S.-focused financial services firm that provides brokerage, custodial and advisory platforms to independent financial advisors, registered investment advisers and institutions. Operating primarily as an independent broker-dealer and custodian, the company supports a network of advisors with the operational, compliance and clearing infrastructure needed to manage client accounts and deliver investment advice outside of traditional wirehouse models.

The firm’s product and service offerings include trade execution and clearing, custody services, retirement plan services, model portfolio and advisory platforms, wealth management technology, investment research and product access across equities, fixed income, mutual funds, exchange-traded funds and insurance and annuity solutions.

Featured Articles Five stocks we like better than LPL Financial Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise Alcoa’s Gallium Project Opens a New Door Beyond Aluminum Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech Can Tesla’s Flying Roadster Distract From Its Real Risks? Want to see what other hedge funds are holding LPLA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LPL Financial Holdings Inc. (NASDAQ:LPLA – Free Report).

Receive News & Ratings for LPL Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LPL Financial and related companies with MarketBeat.com's FREE daily email newsletter.

Key Takeaways Attruby sales reached $403 million in the first half of 2026, supporting BBIO's growth.BBP-418, encaleret and infigratinib offer catalysts that could broaden BBIO's commercial base.BBIO's 12.0X forward EV/Sales valuation leaves less room for execution or regulatory setbacks. BridgeBio Pharma (BBIO - Free Report) shares have gained 24% in the past three months, far ahead of the S&P 500’s 0.7% rise over the same period. The move leaves investors weighing whether improving commercial and pipeline momentum can support further gains.

Attruby’s growth and multiple regulatory catalysts strengthen the fundamental case. Still, a rich valuation and meaningful execution risk leave less room for disappointment after the recent advance.

BBIO’s Three-Month Rally Sets a Higher BarThe stock’s three-month gain extends a much larger 71.4% advance over the past year. That compares with gains of 6.6% for its Zacks sub-industry and 12.4% for the Zacks Medical sector over three months.

Over the past year, the sub-industry and sector rose 32.5% and 13.1%, respectively. BBIO’s outperformance raises the bar for future results, making continued operating progress more important as investors assess the next leg of the stock’s move.

Attruby Growth Gives BBIO Fundamental SupportAttruby generated $403 million in U.S. sales during the first half of 2026 after producing $362.4 million in 2025. BridgeBio also said Attruby continued gaining share among treatment-naive patients in the second quarter, while diagnosed ATTR-CM patients in the United States exceeded 50,000 in 2025.

The competitive backdrop remains important. Pfizer Inc. (PFE - Free Report) remains an established competitor through the Vyndaqel family. Alnylam Pharmaceuticals, Inc. (ALNY - Free Report) also competes with Amvuttra in ATTR-CM. Continued first-line adoption and broader diagnosis will therefore be key to sustaining Attruby’s growth.

BBIO’s Pipeline Adds Near-Term Upside CatalystsBBP-418 is the closest major regulatory event, with an FDA decision expected by Nov. 27, 2026, for limb-girdle muscular dystrophy type 2I/R9. If approved, it could become the first therapy for that patient population, and BridgeBio has said it is prepared to launch upon approval.

Encaleret has an FDA decision date of May 8, 2027, for autosomal dominant hypocalcemia type 1. Infigratinib adds another potential launch, with BridgeBio targeting early to mid-2027 in achondroplasia. Successful approvals would broaden the commercial base beyond Attruby.

Valuation Could Limit Further BBIO UpsideBBIO trades at 12.0X forward 12-month EV/Sales, well above 2.9X for its Zacks sub-industry and 2.6X for the Zacks Medical sector. The S&P 500 trades at 4.8X on the same measure.

That premium leaves less valuation support if commercial execution slows or regulatory outcomes disappoint. Continued Attruby growth and successful pipeline conversion may be needed for the stock to sustain a premium multiple after its recent rally.

BBIO’s Mixed Signals Keep Expectations in CheckThe bottom line is that BBIO has credible growth drivers, but the stock already discounts meaningful progress. Attruby is scaling quickly and several late-stage assets could diversify revenues, while competition, regulatory risk and valuation remain important offsets.

BBIO currently carries a Zacks Rank #3 (Hold), with a Growth Score of B, Value Score of F, Momentum Score of D and VGM Score of D. The favorable Growth Score points to stronger growth characteristics, but the weaker value, momentum and combined scores temper the near-term setup. That mix supports a measured view rather than assuming the three-month rally will continue at the same pace. 

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

 | Source: BridgeBio Pharma, Inc.

- Acoramidis is the first therapy shown to potentially reverse cardiac structural disease progression and functional decline through 42 months based on CMR imaging, with up to half of patients showing clinically meaningful improvement in cardiac function in the completer analysis

- Patients treated with acoramidis were observed to have an unprecedented 65 additional days alive and out of the hospital by Month 36 versus baseline placebo patients

- Acoramidis demonstrated long-term efficacy and safety through 54 months across variant ATTR-CM subgroups, including p.Val142Ile and non-p.Val142Ile. These findings were simultaneously published in the European Journal of Heart Failure

PALO ALTO, Calif., Aug. 30, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for genetic conditions, presented new analyses from the Phase 3 ATTRibute-CM study of Attruby® (acoramidis) in transthyretin amyloid cardiomyopathy (ATTR-CM), including the cardiac magnetic resonance imaging (CMR) substudy and the open-label extension (OLE) at the European Society of Cardiology (ESC) Congress 2026. Acoramidis is the only selective small molecule, orally administered, near-complete (≥90%) transthyretin (TTR) stabilizer.

“The clinical community is excited about the potential to restore heart health found in these data. For a long time, patients living with ATTR-CM could only hope for a stop to the otherwise relentless progression of disease. These new CMR data from ATTRibute-CM shows evidence of reversal in a meaningful proportion of individuals treated with acoramidis, with roughly half showing improved left ventricular systolic function in the completer analysis, more than 2x the proportion observed in the natural history from a NAC cohort or in ATTRibute-CM participants treated with placebo. These findings support acoramidis as a therapy capable of altering the trajectory of this otherwise progressive disease,” said Marianna Fontana, M.D. of University College London, UK. “For patients and clinicians navigating ATTR-CM, this is an exciting signal that the treatment paradigm is shifting toward a therapy that could actively restore heart health rather than only manage decline.”

The CMR substudy of ATTRibute-CM and its open-label extension provide the first evidence from serial CMR that a therapy can potentially reverse disease progression through Month 42. The findings presented by Awais Sheikh, MBChB of the National Amyloidosis Centre, London, UK were evaluated using two complementary analytical approaches, which found:

In a completer analysis, clinically meaningful improvement from baseline in left ventricular (LV) systolic function was observed in 54% of acoramidis-treated patients versus 20% of placebo-treated patients at Month 30, and in 53% of continuous-acoramidis patients at Month 42For context, only 26% of completers in an independent natural history cohort demonstrated improved LV systolic function by Month 24 – approximately half the rate observed with acoramidis, suggesting that this magnitude of improvement falls outside the expected natural course of diseaseIn a conservative analysis, long-term acoramidis treatment was associated with clinically meaningful improvement from baseline in LV systolic function in approximately one-third of patients over 30-42 months. Improvement was observed in 34% of acoramidis-treated patients versus 9% of placebo-treated patients at Month 30 and in 30% of continuous-acoramidis patients at Month 42In addition, 46% of patients receiving continuous acoramidis demonstrated improvement from baseline in LV mass index at Month 42, providing evidence of favorable structural remodelingThese results provided sufficient evidence for BridgeBio to recently dose its first participant in ASCEND-ATTR, a Phase 3b/4 study designed to determine if acoramidis is associated with sustained improvement in myocardial structural disease progression, function and amyloid burden In a post-hoc analysis of ATTRibute-CM presented by Richard Wright, M.D. of the Pacific Heart Institute, U.S., acoramidis preserved significantly more time alive outside the hospital for patients with ATTR-CM. The analysis evaluated days lost to death and/or cardiovascular-related hospitalization (DLDCVH), a patient-centered measure that integrates all-cause mortality, cardiovascular-related hospitalizations, and length of stay into a single assessment of disease burden. Key findings included:

In participants with ATTR-CM, acoramidis reduced the estimated mean percentage of DLDCVH to 7.5% versus 11.7% with placebo through Month 30Acoramidis preserved more than one month of additional time alive and out of the hospital (38 days) over 30 months with the benefit nearly doubling to 65 days (observed) over three years, and nearly tripling to up to 94 days (modelled estimates) over three years, reflecting progressive divergence in outcomes over time The p.Val142Ile genetic variant is the most common ATTR-CM genetic variant globally, disproportionately affecting individuals of Western African ancestry, with a carrier frequency of 3-4% in the U.S. Black population. Findings in the ATTRibute-CM OLE presented by Kevin Alexander, M.D. of Stanford University School of Medicine, U.S. showed continued benefit of acoramidis in 56 variant ATTR-CM (ATTRv-CM) patients, including 35 p.Val142Ile and 21 non-p.Val142Ile patients through Month 54, demonstrating:

All-cause mortality (ACM) and cardiovascular mortality (CVM) were markedly lower in the continuous acoramidis arm versus placebo-to-acoramidis across both p.Val142Ile and non-p.Val142Ile variant subgroupsThrough Month 54, ACM was 30.4% with continuous acoramidis versus 66.7% with placebo-to-acoramidis in the p.Val142Ile subgroup, and 24.3% with continuous acoramidis versus 57.9% with placebo-to-acoramidis across the overall ATTRv-CM population, a consistent, more than two-fold difference in mortality favoring continuous treatmentThe ACM and CVM rates at Month 54 were notably high (~65%) in the p.Val142Ile group who were randomized to placebo in ATTRibute-CM, underscoring the substantial unmet medical need in this high-risk subgroupContinuous acoramidis achieved sustained increases in serum TTR (sTTR) and persistent attenuation of N-terminal pro-B-type natriuretic peptide (NT-proBNP) rise through Month 54 in both participants with p.Val142Ile or non-p.Val142Ile variantsThese Month 54 findings extend the survival benefit and favorable biomarker trends previously reported at Month 30, demonstrating the long-term durability of efficacy and safety of acoramidis in ATTRv-CM, including in the p.Val142Ile subgroupAcoramidis remained well tolerated through Month 54, with no new safety signals observed in the OLE In addition to the one oral presentation and two moderated posters highlighted, two additional moderated posters on acoramidis were shared at the ESC Congress 2026, including:

Acoramidis Improves Health-Related Quality of Life in Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy: An EQ-5D-5L Subgroup Analysis from ATTRibute-CM, presented by Emer Joyce, M.D., Ph.D. of The Mater Misericordiae University Hospital, IE Treatment with acoramidis resulted in significant and clinically meaningful benefits in health-related quality of life (HRQoL) in both wild-type ATTR-CM (ATTRwt-CM) and ATTRv-CM. Greater impact on HRQoL versus placebo was observed in participants with ATTRv-CM Improvement of Health Status with Acoramidis in Patients with Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy: KCCQ Domains Analysis from the ATTRibute-CM Study, presented by Nitasha Sarswat, M.D. of University of Chicago Medical Center, U.S. In ATTRibute-CM, acoramidis attenuated the decline in heart failure-related health status versus placebo in participants with ATTRwt-CM and ATTRv-CM, with consistent benefits observed across Kansas City Cardiomyopathy Questionnaire Overall Summary (KCCQ-OS) and individual domain scores. A numerical improvement was observed across almost all KCCQ domains in acoramidis-treated participants with ATTRwt-CM and ATTRv-CM relative to placebo As part of BridgeBio's partnership with Yale's Cardiovascular Data Science (CarDS) Lab to advance AI networks for earlier detection of ATTR-CM, three posters were presented at the ESC Congress 2026. Findings from the partnership included:

A Novel AI-Derived Digital Biomarker for Monitoring Disease Progression in ATTR-CM: First-In-Trial Use of a Computer Vision AI-ECG Algorithm within a Phase 3 Pivotal Randomized Controlled Trial, presented by Rohan Khera, M.D. of Yale School of Medicine, U.S. This showed the first deployment of a computer vision AI-ECG algorithm, operating directly on ECG data, as a digital biomarker in a RCT (ATTRibute-CM). An image-based AI-ECG algorithm demonstrated discrimination across clinical subgroups at baseline and detected differential longitudinal changes between acoramidis and placebo over 30 months. These findings support the potential role of AI-ECG derived prediction scores as a scalable digital biomarker in clinical trials and potential routine cardiovascular care A Fully Decentralized, Patient-Led Digital Registry for ATTR-CM Integrating Multisystem EHR and Wearable Data: The DISCOVER-ATTR Study, presented by Aline Pedroso, Ph.D. of Yale School of Medicine A fully decentralized, patient-led digital registry can successfully aggregate longitudinal multisystem electronic health records (EHR) data and wearable physiologic signals in ATTR-CM. Early results show substantial data yield and feasibility of longitudinal mapping of care trajectories and multimodal risk prediction, providing a blueprint for next-generation registries in rare cardiovascular diseases Nationwide U.S. Federated Deployment of Artificial Intelligence for Multimodal Screening of ATTR Cardiomyopathy: First Multicenter Analysis from the TRACE-AI Network, presented by Bruno Batinica, MBChB of Yale School of Medicine In this largest-ever deployment of AI-electrocardiogram and AI-Echo models for opportunistic retrospective screening of individuals at risk of ATTR-CM, we demonstrate a large burden of probable undiagnosed ATTR-CM with prognostic implications. Leveraging this framework for screening holds promise for enabling broad, timely identification of patients to maximize the overall benefit of new therapies Acoramidis is approved as Attruby® by the U.S. FDA and is approved as BEYONTTRA® by the European Medicines Agency (EMA), Japanese Pharmaceuticals and Medical Devices Agency, Swissmedic, the Swiss Agency for Therapeutic Products, the UK Medicines and Healthcare Products Regulatory Agency, and the Brazilian Health Regulatory Agency (ANVISA) with all labels specifying near-complete stabilization of TTR.

Additional data on the benefit of Attruby for individuals with ATTR-CM is planned for future medical meetings, including Heart Failure Society of America (HFSA) Annual Scientific Meeting 2026, taking place in Phoenix, Arizona on October 9-12, 2026.

About Attruby® (acoramidis)
INDICATION
Attruby is a transthyretin stabilizer indicated for the treatment of the cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM) in adults to reduce cardiovascular death and cardiovascular-related hospitalization.

IMPORTANT SAFETY INFORMATION
Adverse Reactions
Diarrhea (11.6% vs 7.6%) and upper abdominal pain (5.5% vs 1.4%) were reported in patients treated with Attruby versus placebo, respectively. The majority of these adverse reactions were mild and resolved without drug discontinuation. Discontinuation rates due to adverse events were similar between patients treated with Attruby versus placebo (9.3% and 8.5%, respectively).

BridgeBio Forward-Looking Statements
This press release contains forward-looking statements. Statements in this press release may include statements that are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended (the Securities Act), and Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), which are usually identified by the use of words such as “anticipates,” “believes,” “continues,” “estimates,” “expects,” “hopes,” “intends,” “may,” “plans,” “projects,” “remains,” “seeks,” “should,” “will,” and variations of such words or similar expressions. BridgeBio intends these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Exchange Act. These forward-looking statements include statements regarding the potential clinical significance and therapeutic implications of the data presented regarding acoramidis, including the potential clinical and therapeutic implications of observed changes in cardiac structure and function and the potential for acoramidis to alter the trajectory of ATTR-CM and restore heart health; the potential utility of AI-based tools and digital biomarkers for the detection, monitoring and screening of ATTR-CM in clinical trials and clinical practice; and BridgeBio’s plans to present additional data regarding Attruby at future medical meetings. Although the Company believes that its plans, intentions, expectations and strategies as reflected in or suggested by those forward-looking statements are reasonable, the Company can give no assurance that the plans, intentions, expectations or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a number of risks, uncertainties and assumptions, including, but not limited to, initial and ongoing data from the Company’s clinical trials not being indicative of final data, the design and success of ongoing and planned clinical trials, the risk that results from post hoc analyses, subgroup analyses or other analyses may not be predictive of future clinical outcomes or treatment effects, that observed improvements in cardiac structure, function or other measures may not be replicated in additional analyses or studies or translate into improved long-term clinical outcomes, that the potential utility of AI-based tools and digital biomarkers may not be demonstrated in further studies or translate into routine clinical use, that plans to present additional data may change, the impacts of current macroeconomic and geopolitical events, including changing conditions from hostilities in Ukraine and in Israel and the Middle East, increasing rates of inflation and changing interest rates, on business operations and expectations, as well as those risks set forth in the Risk Factors section of the Company’s most recent Quarterly Report on Form 10-Q and Annual Report on Form 10-K and the Company’s other filings with the U.S. Securities and Exchange Commission. Moreover, the Company operates in a very competitive and rapidly changing environment in which new risks emerge from time to time. These forward-looking statements are based upon the current expectations and beliefs of the Company’s management as of the date of this press release, and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Except as required by applicable law, BridgeBio assumes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

About BridgeBio
BridgeBio exists to develop transformative medicines for genetic conditions. Millions of people worldwide living with genetic conditions lack treatment options, often because drug development for small patient populations can be commercially challenging. We aim to bridge the gap between advancements in genetic science and meaningful medicines for underserved patient populations. Our decentralized, hub-and-spoke model is designed for speed, precision, and scalability. Autonomous and empowered teams focus on individual conditions, while a central hub provides the clinical, regulatory, and commercial capabilities needed to bring innovation to market. For more information, visit bridgebio.com and follow us on LinkedIn, X, Facebook, Instagram, YouTube, and TikTok.

BridgeBio Media Contact:
Kaitlyn Reilly, Director, Communications
[email protected]
(650) 789-8220

BridgeBio Investor Contact:
Kristen Kelleher, Director, Investor Relations
[email protected]

Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of Badger Meter, Inc. (NYSE:BMI – Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 14,436 shares of the scientific and technical instruments company’s stock, valued at approximately $2,142,000.

Several other large investors also recently added to or reduced their stakes in BMI. Caitong International Asset Management Co. Ltd grew its position in Badger Meter by 76.5% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 150 shares of the scientific and technical instruments company’s stock worth $26,000 after acquiring an additional 65 shares during the period. Godfrey Financial Associates Inc. purchased a new stake in Badger Meter in the fourth quarter valued at $27,000. Dunhill Financial LLC purchased a new stake in Badger Meter in the second quarter valued at $28,000. Frazier Financial Advisors LLC acquired a new position in shares of Badger Meter in the 2nd quarter valued at $30,000. Finally, Brown Brothers Harriman & Co. lifted its stake in shares of Badger Meter by 62.3% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 185 shares of the scientific and technical instruments company’s stock valued at $33,000 after purchasing an additional 71 shares during the last quarter. 89.01% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes BMI has been the subject of several research reports. Zacks Research upgraded shares of Badger Meter from a “strong sell” rating to a “hold” rating in a report on Monday, July 6th. Weiss Ratings upgraded Badger Meter from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Tuesday, July 28th. JPMorgan Chase & Co. lowered their price target on Badger Meter from $172.00 to $170.00 and set an “overweight” rating for the company in a research report on Thursday, July 23rd. Seaport Research Partners set a $160.00 price objective on Badger Meter in a research note on Thursday, July 23rd. Finally, Barclays reiterated an “underweight” rating and issued a $112.00 price objective (up from $109.00) on shares of Badger Meter in a report on Tuesday, July 28th. Five equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $164.00.

Get Our Latest Stock Report on Badger Meter Badger Meter Stock Down 1.8% BMI opened at $135.68 on Friday. The firm has a market cap of $3.93 billion, a price-to-earnings ratio of 31.70, a price-to-earnings-growth ratio of 2.43 and a beta of 0.65. Badger Meter, Inc. has a 52 week low of $112.09 and a 52 week high of $204.00. The business’s 50 day moving average is $137.64 and its two-hundred day moving average is $138.74.

Badger Meter (NYSE:BMI – Get Free Report) last released its quarterly earnings results on Wednesday, July 22nd. The scientific and technical instruments company reported $1.02 EPS for the quarter, beating the consensus estimate of $1.01 by $0.01. Badger Meter had a net margin of 14.27% and a return on equity of 18.03%. The firm had revenue of $220.30 million during the quarter, compared to the consensus estimate of $220.59 million. During the same quarter in the prior year, the firm earned $1.17 EPS. Badger Meter’s revenue for the quarter was down 6.6% on a year-over-year basis. Equities analysts expect that Badger Meter, Inc. will post 4.5 EPS for the current fiscal year.

Badger Meter Increases Dividend The company also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Friday, August 28th will be issued a $0.44 dividend. The ex-dividend date of this dividend is Friday, August 28th. This is a positive change from Badger Meter’s previous quarterly dividend of $0.40. This represents a $1.76 annualized dividend and a dividend yield of 1.3%. Badger Meter’s payout ratio is presently 37.38%.

Insider Activity In other news, VP Edward F. Callahan acquired 751 shares of Badger Meter stock in a transaction that occurred on Thursday, July 30th. The stock was purchased at an average price of $135.25 per share, for a total transaction of $101,572.75. Following the completion of the transaction, the vice president directly owned 1,937 shares in the company, valued at approximately $261,979.25. This trade represents a 63.32% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 1.00% of the stock is currently owned by company insiders.

About Badger Meter (Free Report)

Badger Meter, founded in 1905 and headquartered in Milwaukee, Wisconsin, is a global leader in flow measurement and control solutions. The company’s core business centers on the design, manufacture and sale of water meters, control valves and related accessories for municipal and industrial water utilities. Over its more than a century of operation, Badger Meter has built a reputation for precision engineering, durability and compliance with international regulatory standards.

The company’s product portfolio includes mechanical and ultrasonic water meters, electromagnetic flow meters for industrial applications, and a range of control valves that help utilities manage pressure and flow in distribution networks.

Further Reading Five stocks we like better than Badger Meter From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash Venture Into High-Volatility Corners of the Market With These 3 ETFs 3 Retail Stocks to Watch After a Big Consumer Earnings Week Want to see what other hedge funds are holding BMI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Badger Meter, Inc. (NYSE:BMI – Free Report).

Receive News & Ratings for Badger Meter Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Badger Meter and related companies with MarketBeat.com's FREE daily email newsletter.

Key Takeaways MaxLinear leads with meaningful AI revenues, hyperscaler deployments and a broad connectivity pipeline.MXL expects Rushmore, Washington and Annapurna to become growth drivers as deployments ramp from 2027.Vicor offers VPD upside and a stronger balance sheet, but its biggest AI catalyst remains earlier-stage. MaxLinear (MXL - Free Report) and Vicor (VICR - Free Report) both stand to benefit from accelerating AI infrastructure spending, but they address different bottlenecks inside the data center. MaxLinear is primarily exposed to the connectivity side of AI infrastructure through high-speed optical and electrical interconnects, while Vicor focuses on power delivery for increasingly power-dense AI processors.

So, MXL or VICR, which is a better buy under the current scenario?

The Case for MaxLinearMaxLinear currently has the more visible AI revenue ramp. In the second quarter of 2026, revenues jumped 55% year over year to $168.8 million, while Infrastructure revenues surged 145% to $85 million and represented roughly half of total revenues. The year-over-year growth was driven primarily by higher shipments of optical, high-performance analog and wireless-backhaul products. Infrastructure has become MXL’s largest revenue category, led by high-speed optical interconnect demand.

The company’s AI opportunity is already moving beyond a single product. Keystone, MaxLinear’s 100G-per-lane PAM4 (Pulse Amplitude Modulation 4-Level) DSP (Digital Signal Processor), is in high-volume production at major U.S. and Asian hyperscalers for 400G and 800G deployments. MaxLinear expects the 1.6T Rushmore PAM4 DSP to become an important growth driver beginning in 2027. Washington expands MaxLinear into 200G-per-lane TIAs, while Annapurna targets 1.6T active electrical cables and onboard retimers used for low-latency AI scale-up connectivity. Washington and Annapurna are expected to begin generating revenues in 2027, followed by a more meaningful ramp in 2028.

MaxLinear is also gaining AI content beyond optical connectivity. The company has completed qualification of an XGS-PON hyperscaler design for data-center control-plane applications and secured USB bridge-controller wins at two major hyperscalers for AI rack management. MXL’s Panther storage accelerators address CPU, memory and storage bottlenecks, with revenues expected to roughly double in 2026 and potentially nearly double again in 2027. This combination of optics, electrical interconnects, storage, rack management and power-management products gives MXL several ways to increase content per AI rack.

The Case for VicorVicor's AI opportunity centers on solving another critical constraint, supplying large amounts of power to increasingly dense GPUs, TPUs and other accelerators. Advanced Products generated $94.2 million in the second quarter of 2026, up 45% sequentially, and accounted for 65.7% of revenues. Advanced Products sales are currently concentrated in data-center and hyperscaler applications, including power delivery on server motherboards, inside racks and across data-center infrastructure. The company also identifies AI processor acceleration as an important market for its power technology.

Vicor is leveraging second-generation Vertical Power Delivery (VPD) architecture to drive growth. The company targets current gain above 40 and current density of as much as 5 amps per square millimeter, addressing the rising power-density requirements of AI systems. However, the technology remains earlier in its commercialization curve than MaxLinear’s Keystone platform. Vicor has completed an initial chipset for its lead customer at roughly 3 amps per square millimeter and is completing demonstration systems, while targeting more than 4 amps per square millimeter around late 2026 or early 2027. Broader hyperscaler and OEM design wins therefore represent substantial upside, but their timing is still less certain.

Vicor nevertheless has strong demand indicators and a considerably stronger balance sheet. Backlog reached approximately $380 million in the second quarter of 2026, rising 26% sequentially and 145% year over year. Cash stood at $453.6 million, while operating cash flow totaled $34 million in the reported quarter. Rising high-performance computing and AI-related demand is bringing the first ChiP fabrication facility toward full utilization, prompting Vicor to prepare for additional manufacturing capacity.

MXL & VICR’s Earnings Estimate Revisions SteadyThe Zacks Consensus Estimate for MaxLinear’s 2026 earnings is pegged at $1.74 per share, unchanged over the past 30 days. MXL reported earnings of 31 cents per share in 2025.
 

The consensus mark for VICR’s 2026 earnings has been steady at $3.12 per share over the past 30 days and suggests 19.54% growth from the figure reported in 2025.

Stock Price Performance and ValuationMXL shares have returned 263.9% year to date, outperforming Vicor’s appreciation of 85.8%.

Price Performance: MXL vs. VICR
 
Image Source: Zacks Investment Research

Valuation-wise, shares of both MXL and VICR are overvalued. In terms of trailing 12-month EV/sales, MaxLinear shares are trading at 10.21X, lower than Vicor’s 18.85X.

Both MaxLinear and Vicor have a Value Score of F.

MXL and VICR Valuation
Image Source: Zacks Investment Research

Conclusion: MXL Has the EdgeMaxLinear appears better positioned to capture the AI infrastructure boom in the near to medium term. Vicor offers compelling long-term upside from second-generation VPD and has the stronger balance sheet, but its biggest AI catalyst is still moving through development, customer evaluation and eventual production ramps. MXL already has meaningful AI-driven revenues, high-volume hyperscaler deployments and a broader pipeline spanning 800G, 1.6T, electrical scale-up, rack management and storage. The combination of stronger current AI revenue growth and multiple identifiable product ramps through 2027-2028 gives MXL the edge over VICR, albeit with higher customer concentration and balance-sheet risk.

MaxLinear and Vicor currently carry Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Bank of Nova Scotia bought a new position in Avery Dennison Corporation (NYSE:AVY – Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 25,452 shares of the industrial products company’s stock, valued at approximately $4,132,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in AVY. BlackRock Inc. bought a new stake in Avery Dennison during the second quarter worth approximately $1,052,464,000. Norges Bank bought a new stake in shares of Avery Dennison in the 4th quarter valued at approximately $188,438,000. Morgan Stanley boosted its holdings in shares of Avery Dennison by 20.1% in the 4th quarter. Morgan Stanley now owns 3,869,889 shares of the industrial products company’s stock worth $703,856,000 after purchasing an additional 647,795 shares during the period. Wellington Management Group LLP increased its position in shares of Avery Dennison by 12.5% during the 3rd quarter. Wellington Management Group LLP now owns 5,808,960 shares of the industrial products company’s stock valued at $942,039,000 after purchasing an additional 644,664 shares during the last quarter. Finally, Bank of New York Mellon Corp bought a new position in shares of Avery Dennison during the 2nd quarter valued at approximately $101,896,000. 94.17% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades AVY has been the topic of several recent analyst reports. JPMorgan Chase & Co. increased their target price on shares of Avery Dennison from $185.00 to $190.00 and gave the company an “overweight” rating in a research note on Friday, July 31st. Truist Financial dropped their price target on shares of Avery Dennison from $221.00 to $209.00 and set a “buy” rating for the company in a research note on Wednesday, July 15th. Bank of America reiterated a “buy” rating on shares of Avery Dennison in a report on Friday, August 14th. Argus set a $175.00 price objective on shares of Avery Dennison in a research report on Thursday, June 4th. Finally, Wall Street Zen raised shares of Avery Dennison from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Seven equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $201.22.

Get Our Latest Research Report on Avery Dennison Avery Dennison Stock Down 1.9% Shares of Avery Dennison stock opened at $180.12 on Wednesday. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 0.79. The stock has a market cap of $13.65 billion, a price-to-earnings ratio of 19.73, a PEG ratio of 2.34 and a beta of 0.81. The firm’s 50-day moving average is $167.64 and its two-hundred day moving average is $170.09. Avery Dennison Corporation has a 1 year low of $152.42 and a 1 year high of $199.54.

Avery Dennison (NYSE:AVY – Get Free Report) last announced its earnings results on Thursday, July 30th. The industrial products company reported $2.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.47 by $0.42. Avery Dennison had a return on equity of 34.60% and a net margin of 7.62%.The business had revenue of $2.46 billion for the quarter, compared to analysts’ expectations of $2.30 billion. During the same quarter last year, the firm earned $2.42 EPS. The business’s revenue for the quarter was up 10.9% on a year-over-year basis. Avery Dennison has set its Q3 2026 guidance at 10.000-10.300 EPS. As a group, research analysts expect that Avery Dennison Corporation will post 10.15 earnings per share for the current fiscal year.

Avery Dennison Dividend Announcement The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 16th. Investors of record on Wednesday, September 2nd will be paid a $1.00 dividend. The ex-dividend date is Wednesday, September 2nd. This represents a $4.00 dividend on an annualized basis and a yield of 2.2%. Avery Dennison’s dividend payout ratio (DPR) is 43.81%.

Insider Buying and Selling In other Avery Dennison news, SVP Ignacio J. Walker sold 1,742 shares of the firm’s stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $171.61, for a total transaction of $298,944.62. Following the completion of the transaction, the senior vice president directly owned 7,585 shares of the company’s stock, valued at approximately $1,301,661.85. This trade represents a 18.68% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 0.81% of the company’s stock.

About Avery Dennison (Free Report)

Avery Dennison (NYSE:AVY) is a global materials science and manufacturing company specializing in labeling and packaging solutions. The company develops pressure-sensitive materials, tags and labels, and adhesive technologies that help brands and businesses enhance product identification, branding and supply-chain performance. Avery Dennison’s offerings range from industrial and retail labeling to high-performance tapes, films and graphics materials used across multiple end markets.

The company operates through several key segments, including Label and Graphic Materials, which supplies pressure-sensitive materials for consumer goods; Retail Branding and Information Solutions, offering apparel tags, RFID inlays and digital product identification; Pressure-Sensitive Materials, providing specialty tapes and adhesives; and RF Technologies, focused on advanced RFID and IoT labeling solutions.

Featured Stories Five stocks we like better than Avery Dennison Pathward’s Credit Scare Tests Its Comeback Story Wiring the AI Boom: Rumble’s $13.7B Pivot StoneX: Too Far Too Fast? DICK’s Sporting Goods Faces Pain Now for a Bigger Prize

Receive News & Ratings for Avery Dennison Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avery Dennison and related companies with MarketBeat.com's FREE daily email newsletter.

An estimated $390 billion in stablecoin payments took place in 2025, according to McKinsey and Artemis. But inside this market, AI agents are creating an interesting kind of payment activity.

Research shows that agents completed more than 176 million on-chain transactions worth over $73 million between May 2025 and April 2026. But most of them were very small transactions. 

The median x402 payment was between $0.01 and $0.10, while 76% of transactions fell below the $0.30 fixed-fee threshold for card payments. USDC accounted for 98.6% of settlements.

Annual Stablecoin Payments in 2025. Source: McKinsey Although the transaction amounts are small, the frequency of AI agentic payments is staggering — 173 million.

Software can buy data, compute and other services hundreds or thousands of times without the human behaviors that define conventional commerce. For example, opening an account, entering card details, approving an invoice or waiting until the next banking day.

XDC Network believes this offers an early glimpse of how more payments could work in future.

“Money has always moved as fast as the slowest part of the process, like a bank, a clearinghouse, or normal business hours,” Atul Khekade, Co-Founder of XDC Network, told BeInCrypto. “Agents just show what happens when you get rid of those delays. Payments stop being something you wait around for and turn into a continuous process happening in the background at the speed of the underlying network.”

Machine Payments Software can transact continuously. An AI service may need a weather feed for one calculation, a market-price API several seconds later, and compute resources immediately afterward.

Each interaction can carry its own price, turning what might once have been a monthly subscription or invoice into thousands of individual transactions.

That helps explain why Keyrock found activity spread across such a large population of AI agents and service directories. The report found more than 104,000 agents registered across at least 15 directories by the end of the first quarter of 2026.

The economics favor systems that can handle payments measured in cents or fractions of a cent. The payments industry is already preparing:

Stripe launched the Machine Payments Protocol, or MPP, in March. The open standard allows agents and services to coordinate micropayments and recurring payments programmatically, with Stripe supporting stablecoins as well as traditional payment methods; Google’s Agent Payments Protocol, or AP2, concentrates on proving user authorization and establishing an auditable record of what an agent was permitted to buy. Google transferred the protocol to the FIDO Alliance in April and added support for autonomous “Human Not Present” transactions; Cloudflare entered the market in August with Cloudflare Wallets and cloudflare.pay, giving agents identities and programmable spending controls. Its payment tools support both x402 and MPP; Mastercard’s Agent Pay for Machines service, announced in June, is designed for continuous, high-frequency and low-value payments, with settlement across cards, accounts and stablecoins. More than 30 companies, including Stripe, Coinbase, Cloudflare and Tempo, were named among its initial supporters. 2️⃣ Secure agentic purchases on Google

✅ We designed Agent Payments Protocol (AP2) to help agents make secure payments on your behalf — with boundaries and accountability to give you peace of mind.

✅ AP2 lets you set strict guardrails for agentic payment transactions. Just…

— Google (@Google) May 27, 2026 Invisible Settlement XDC’s contribution to this market is XDCAI.tech, which uses the open x402 protocol originally introduced by Coinbase.

x402 turns the HTTP ‘402 Payment Required’ response into a payment mechanism. An agent requests a resource, receives its price, authorizes the payment, and repeats the request with proof of payment. The process allows software to purchase an API call or another digital service within the same interaction.

Coinbase introduced the protocol in May 2025, and its use has since expanded through integrations with companies including AWS.

XDC AI applies x402 to USDC settlement on XDC Network. Users fund a smart wallet with USDC and establish an on-chain spending limit. An agent can then pay an x402-enabled service per request. EIP-3009 allows the payment to be signed off-chain while a relayer covers the network fee, leaving the agent itself to hold and spend USDC.

For years, AI agents could reason, plan, and execute tasks.

But they couldn't pay.

APIs, subscriptions, checkout pages, and payment flows were built for humans — not autonomous software.

So we built XDC AI.

A platform that gives AI agents a wallet, lets them discover…

— Rushabh Parmar (@rushabh96975767) July 11, 2026 The system can also connect to AI applications through MCP or a command-line interface, allowing agents running through products including ChatGPT, Claude, Cursor, and Codex to discover and pay for services.

XDC already had much of the underlying settlement infrastructure in place. Native USDC and Circle’s CCTP went live on XDC in September 2025.

XDC lists two-second block times, six-second finality, and transaction costs around $0.00001, characteristics aimed at high-volume financial applications.

Invoices Could Disappear Invoices package several functions together. They communicate what is owed, set payment terms, and provide records for reconciliation and accounting. Many businesses then wait days or weeks for the actual transfer to arrive.

Software dealing with software can compress part of that cycle. A service can state its price in a machine-readable format, an authorized agent can evaluate the request, and payment can be settled immediately. Transaction records can then feed directly into treasury and accounting systems.

Next wave of payments = AI + Agentic Commerce.
XDC is building the infrastructure:
• x402 micropayments
• Gasless USDC settlement
• Real-time, sub-cent autonomous payments for AI agents
Tonight in NYC, @atulkhekade shares how we’re making this a reality. The future of… https://t.co/FokrYWhAbw

— XDC Network (@XDCNetwork) July 9, 2026 This comes as agents are taking on increasing responsibility for procurement, cloud spending, portfolio management, and recurring commercial obligations. A company could eventually give an agent a budget and a set of rules, then allow it to buy compute when demand rises, renew services, pay suppliers or rebalance liquidity within those boundaries.

XDC therefore sees today’s one-cent API payment as the smallest version of something much larger.

The card networks see it too. Visa’s stablecoin settlement program reached a $7 billion annualized run rate in April after growing 50% quarter-over-quarter and expanding to nine blockchains. Mastercard announced stablecoin settlement across networks including Ethereum, Solana, Base, Polygon, Tempo and XRPL in June.

The competition is consequently broader than blockchain networks attempting to replace card companies. Visa, Mastercard, Stripe, Google, Coinbase, Cloudflare and blockchain developers are increasingly building interoperable pieces of the same machine-commerce market.

The Other Half of the Problem Greater autonomy raises questions about permission and accountability.

An agent paying 3 cents per API request incurs limited financial exposure. However, an agent managing a corporate treasury or procurement budget needs controls around authorization, counterparties, limits, and auditability, which is why the major platforms are converging on different pieces of the same problem. This explains why:

Google has concentrated on cryptographic mandates that record what a user authorized; Cloudflare lets owners impose spending caps and approved merchant lists; Mastercard’s system combines agent credentials with permissioning rules;  XDC AI places spending limits at the wallet level Those controls determine how quickly agentic payments graduate from micropayments into larger financial relationships.

They also temper the idea that cards and invoices disappear on a fixed timetable. Card networks are already adapting their products for autonomous software, while invoices serve legal, tax, credit and accounting functions that extend beyond transferring funds.

XDC believes that payment and service delivery can happen almost simultaneously: APIs, data, compute, digital services and other machine-to-machine transactions. Success there could establish the habits and technical standards that would later be used for larger transactions.

Khekade expects the terminology itself to disappear as the technology becomes commonplace.

“In 5 years nobody will describe this as agentic payments, the same way nobody today calls a wire transfer an internet payment,” he said. “It will just be how value moves. The interesting question is not whether that happens, it is which networks were actually built for it versus which ones bolted it on afterward.”

Algert Global LLC decreased its position in Exponent, Inc. (NASDAQ:EXPO – Free Report) by 69.8% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 45,120 shares of the business services provider’s stock after selling 104,110 shares during the period. Algert Global LLC owned approximately 0.09% of Exponent worth $2,651,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of EXPO. Northwestern Mutual Wealth Management Co. boosted its holdings in Exponent by 87,479.8% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 230,335 shares of the business services provider’s stock valued at $15,999,000 after acquiring an additional 230,072 shares during the last quarter. UBS Group AG lifted its position in shares of Exponent by 29.7% in the 4th quarter. UBS Group AG now owns 176,404 shares of the business services provider’s stock worth $12,253,000 after purchasing an additional 40,359 shares during the period. Conestoga Capital Advisors LLC lifted its position in shares of Exponent by 1.3% in the 4th quarter. Conestoga Capital Advisors LLC now owns 2,392,499 shares of the business services provider’s stock worth $166,183,000 after purchasing an additional 31,303 shares during the period. Quantinno Capital Management LP lifted its position in shares of Exponent by 114.3% in the 1st quarter. Quantinno Capital Management LP now owns 36,614 shares of the business services provider’s stock worth $2,389,000 after purchasing an additional 19,528 shares during the period. Finally, New Age Alpha Advisors LLC boosted its stake in shares of Exponent by 785.8% in the 4th quarter. New Age Alpha Advisors LLC now owns 24,775 shares of the business services provider’s stock valued at $1,721,000 after purchasing an additional 21,978 shares during the last quarter. Institutional investors own 92.37% of the company’s stock.

Insider Buying and Selling at Exponent In other Exponent news, CEO Catherine Corrigan sold 1,707 shares of the business’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $66.28, for a total transaction of $113,139.96. Following the completion of the sale, the chief executive officer directly owned 129,108 shares of the company’s stock, valued at approximately $8,557,278.24. The trade was a 1.30% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.70% of the stock is owned by corporate insiders.

Analyst Ratings Changes A number of analysts have commented on the stock. JPMorgan Chase & Co. upped their price target on shares of Exponent from $80.00 to $90.00 and gave the company an “overweight” rating in a research report on Friday, July 31st. UBS Group set a $72.00 price objective on Exponent and gave the company a “neutral” rating in a research note on Friday, July 31st. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Exponent in a research report on Friday, July 17th. Two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $81.00. Get Our Latest Stock Report on Exponent

Exponent Stock Performance EXPO stock opened at $71.53 on Friday. The stock’s 50 day simple moving average is $64.33 and its 200 day simple moving average is $64.53. Exponent, Inc. has a fifty-two week low of $51.91 and a fifty-two week high of $81.95. The company has a market cap of $3.40 billion, a P/E ratio of 32.08 and a beta of 0.68.

Exponent (NASDAQ:EXPO – Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The business services provider reported $0.60 EPS for the quarter, beating analysts’ consensus estimates of $0.55 by $0.05. Exponent had a return on equity of 31.48% and a net margin of 17.67%.The firm had revenue of $171.61 million during the quarter, compared to analysts’ expectations of $144.99 million. During the same quarter last year, the firm posted $0.52 earnings per share. The company’s revenue for the quarter was up 12.0% compared to the same quarter last year. Equities analysts predict that Exponent, Inc. will post 2.31 earnings per share for the current year.

Exponent Announces Dividend The firm also recently announced a quarterly dividend, which will be paid on Friday, September 18th. Investors of record on Friday, September 4th will be issued a $0.31 dividend. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date is Friday, September 4th. Exponent’s dividend payout ratio is currently 55.61%.

Exponent Profile (Free Report)

Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.

Featured Stories Five stocks we like better than Exponent 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude? Okta Stock Surges 29%—Is $200 the Next Stop?

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.

AUDUBON, Pa., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the acquisition of Higgs Boson Health, a digital healthcare experience company based in Durham, NC and incubated out of Duke University. With a mission to transform healthcare experience through digital innovation, Higgs Boson will position Globus Medical to shape patient and provider experience throughout the full episode of care.

“Higgs Boson employs highly experienced teams of software developers and AI scientists who will be joining our team to power our vision of a seamless digital healthcare environment to simplify a patient’s journey through our healthcare system while enhancing real-time information and surgical intelligence available to healthcare providers with the ultimate goal of getting to 95% good outcomes at 10 years for all musculoskeletal surgeries,” said David Paul, Founder and Executive Chairman.

“The acquisition of Higgs Boson and its digital solutions represents the next step in our strategy of enhancing the Globus ecosystem,” commented Keith Pfeil, President and Chief Executive Officer. “As we continue to build out the ecosystem, the Higgs Boson technology will be part of our surgical intelligence pillar, bringing together outcomes and analytics in a closed-loop manner that fosters continuous learning, integrating along the full patient journey with the goal of improving patient outcomes.”

About Globus Medical, Inc.

Globus Medical, Inc. is a leading global musculoskeletal technology company dedicated to solving unmet clinical needs and changing lives. We innovate with inspired urgency, provide world-class education and clinical support, and advance care throughout spine, orthopedic trauma, joint reconstruction, biomaterials and enabling technologies. Additional information can be accessed at www.globusmedical.com.

Safe Harbor Statements

All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and other similar terms. These forward-looking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted. These risks and uncertainties include, but are not limited to, the risks and costs associated with health epidemics, pandemics and similar outbreaks, factors affecting our quarterly results, our ability to manage our growth, our ability to sustain our profitability, demand for our products, our ability to compete successfully (including without limitation our ability to convince surgeons to use our products and our ability to attract and retain sales and other personnel), our ability to rapidly develop and introduce new products, our ability to develop and execute on successful business strategies, our ability to comply with laws and regulations that are or may become applicable to our businesses, our ability to safeguard our intellectual property, our success in defending legal proceedings brought against us, trends in the medical device industry, general economic conditions, the successful integration of businesses that we have acquired or may acquire in the future, and other risks. For a discussion of these and other risks, uncertainties, and other factors that could affect our results, refer to the disclosures contained in our most recent Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”), including the sections labeled “Risk Factors” and “Cautionary Note Concerning Forward-Looking Statements,” and in our subsequent filings with the SEC. These documents are available at www.sec.gov. Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from time to time and it is not possible for us to predict all risk factors and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements. Forward-looking statements contained in this press release speak only as of the date of this press release. Except as may be required by applicable law, we undertake no obligation to update any forward-looking statements as a result of new information, events or circumstances or other factors arising or coming to our attention after the date hereof. As used herein, the “Company”, “Globus”, “Globus Medical”, “we”, “us”, and “our” refers to Globus Medical, Inc.

Contact:
Brian Kearns
Senior Vice President, Corporate Development and Investor Relations
Phone: (610) 930-1800
Email: [email protected]
www.globusmedical.com

, /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Smartsheet, Inc. ("Smartsheet" or the "Company") (NYSE: SMAR).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

The class action concerns whether Smartsheet and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

You have until October 5, 2026, to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired Smartsheet securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com. 

[Click here for information about joining the class action]

A class action lawsuit has been filed, alleging that defendants, throughout the Class Period, failed to disclose material information, which artificially deflated the price of Smartsheet common stock.

On January 24, 2024, Smartsheet received an unsolicited non-public offer from Blackstone Inc. and Vista Equity Partners Management, LLC (together, the "Consortium") to purchase all the outstanding shares of Smartsheet for $56.25 per share.  In April 2024, Smartsheet's Board of Directors approved a share repurchase program under which Smartsheet could repurchase up to $150 million of its outstanding stock.  On July 8, 2024, the Consortium raised its offer to $56.50 per share.  Subsequently, on August 21, 2024, the Consortium reiterated its offer to purchase all the outstanding shares of Smartsheet at $56.50 per share.  The class action lawsuit alleges that while these offers were on the table and unknown to the investing public, Smartsheet was repurchasing its common stock at market prices significantly below the prices offered by the Consortium.  Smartsheet had an obligation to disclose that it had received a formal acquisition offer from the Consortium or abstain from purchasing Smartsheet stock from unsuspecting investors.

During the Class Period (i.e., between June 1, 2024 and September 23, 2024), Smartsheet's average stock price was $46.45 per share.  September 24, 2024, during pre-market hours, Smartsheet disclosed the transaction with the Consortium.  The merger eventually closed on January 22, 2025, with the Consortium acquiring Smartsheet for $56.50 per share.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising.  Prior results do not guarantee similar outcomes.

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980

SOURCE Pomerantz LLP

A month has gone by since the last earnings report for Sensata (ST - Free Report) . Shares have lost about 11.5% in that time frame, underperforming the S&P 500.

Will the recent negative trend continue leading up to its next earnings release, or is Sensata due for a breakout? Well, first let's take a quick look at its latest earnings report in order to get a better handle on the recent drivers for Sensata Technologies Holding N.V. before we dive into how investors and analysts have reacted as of late.

Sensata Q2 Earnings Beat on Broad Growth and Productivity Gains

Sensata reported second-quarter 2026 adjusted earnings of 98 cents per share, up 12.6% year over year. The figure beat the consensus estimate of 93 cents by 5.4%, supported by higher revenues and productivity gains.

Revenues of $990.60 million increased 5.0% and surpassed the consensus estimate of $969.57 million by 2.2%. Organic growth was 4.4%, with all three segments expanding. On-road truck orders grew at a double-digit pace, reinforcing management’s view of a second-half recovery in North American truck builds.

Operating Margin Advances on Productivity

Adjusted operating income rose 8.0% year over year to $193.30 million. The adjusted operating margin expanded 50 basis points to 19.5%, reflecting stronger volumes and improved productivity. Adjusted gross profit increased 7.4% to $313.80 million, with the corresponding margin rising 70 basis points to 31.7%.

Adjusted selling, general and administrative expenses climbed to $88.50 million from $80.60 million. Adjusted corporate operating expenses increased to $60.90 million from $51.10 million, mainly due to higher variable compensation tied to stronger performance. Research and development expenses declined to $31.90 million from $32.60 million.

Automotive Portfolio Drives Outgrowth

Automotive revenues increased 3.3% year over year to $544.80 million, while organic sales rose 1.8%. Content gains and production mix helped the segment outperform flat global vehicle production. Revenues from both internal-combustion and electric-vehicle applications outgrew production in North America and Europe.

Segment operating income improved to $131.70 million from $121.10 million, lifting margin 120 basis points to 24.2%. India automotive revenues exceeded $20 million in the quarter and grew more than 40%, supported by local customer wins and the company’s localization strategy.

Other Segments Deliver Organic Growth

Aerospace, Defense and Commercial Equipment revenues advanced 11.5% to $233.70 million, including 10.9% organic growth. Operating income rose to $65.10 million from $51.20 million, and margin expanded 340 basis points to 27.8% on strong volume leverage. Revenue growth extended across aerospace, defense, on-road trucks and off-highway equipment.

Industrials revenues grew 2.9% to $212.10 million and increased 4.2% organically, aided by share gains and stabilizing U.S. HVAC production. Operating income slipped to $57.50 million from $57.90 million, while margin contracted 100 basis points to 27.1%. Sensata invested roughly $1.50 million of incremental operating expenses in data center growth initiatives.

Data Center Opportunity Expands

The company secured three additional hyperscaler concept specifications in the quarter, bringing the year-to-date total to five across four major hyperscalers. Sensata was also named a preferred vetted vendor by a major hyperscaler. One specification led to an award for pressure and temperature sensors in coolant distribution units, with shipments expected to begin in the first quarter of 2027.

Management expects the addressable market per megawatt to expand 1.5 to 2.5 times as data centers adopt higher-voltage architectures, liquid cooling and more on-site power generation. Revenue from related industrial components approximately doubled in the first half of 2026 from the prior-year period.

Cash Generation Supports Deleveraging

Net cash from operating activities increased 49.0% to $210.00 million. Free cash flow jumped 61.4% to $186.40 million, and conversion improved to 130% of adjusted net income from 91%. Working-capital initiatives reduced the cash conversion cycle by about 15 days over the past 18 months.

ST used $400 million of cash to retire roughly $406 million of long-term debt. Gross debt ended the quarter at $2.46 billion, while net debt was $2.06 billion. Net leverage declined to 2.4 times trailing 12-month adjusted EBITDA from 3.0 times a year ago. Return on invested capital rose 120 basis points to 11.3%.

Q3 Guidance Points to Growth

For the third quarter of 2026, Sensata expects revenues of $957-$987 million, representing growth of 3-6% from $932 million a year earlier. Adjusted operating income is projected at $186-$193 million, with an adjusted operating margin of 19.4-19.6%.

Adjusted earnings are forecast at 93-97 cents per share, up 4-9% from 89 cents. The outlook includes about $10 million each of tariff costs and customer pass-through revenues, leaving adjusted operating income, net income and earnings unaffected. Seasonal European automotive shutdowns are expected to weigh on sequential revenues.

How Have Estimates Been Moving Since Then?It turns out, fresh estimates have trended upward during the past month.

VGM ScoresCurrently, Sensata has a nice Growth Score of B, though it is lagging a lot on the Momentum Score front with a D. However, the stock has a score of A on the value side, putting it in the top quintile for this investment strategy.

Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.

OutlookEstimates have been trending upward for the stock, and the magnitude of this revision looks promising. Interestingly, Sensata has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.

Performance of an Industry PlayerSensata belongs to the Zacks Instruments - Control industry. Another stock from the same industry, Badger Meter (BMI - Free Report) , has gained 6% over the past month. More than a month has passed since the company reported results for the quarter ended June 2026.

Badger Meter reported revenues of $222.32 million in the last reported quarter, representing a year-over-year change of -6.6%. EPS of $1.02 for the same period compares with $1.17 a year ago.

Badger Meter is expected to post earnings of $1.21 per share for the current quarter, representing a year-over-year change of +1.7%. Over the last 30 days, the Zacks Consensus Estimate has changed +1.2%.

Badger Meter has a Zacks Rank #3 (Hold) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of D.

Deutsche Bank AG purchased a new position in shares of Broadstone Net Lease, Inc. (NYSE:BNL – Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 279,117 shares of the company’s stock, valued at approximately $5,769,000. Deutsche Bank AG owned 0.15% of Broadstone Net Lease at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Royal Bank of Canada raised its holdings in shares of Broadstone Net Lease by 69.9% during the 1st quarter. Royal Bank of Canada now owns 91,943 shares of the company’s stock valued at $1,566,000 after buying an additional 37,830 shares during the period. AQR Capital Management LLC grew its position in Broadstone Net Lease by 52.8% in the first quarter. AQR Capital Management LLC now owns 25,599 shares of the company’s stock valued at $436,000 after acquiring an additional 8,848 shares in the last quarter. Millennium Management LLC raised its stake in shares of Broadstone Net Lease by 2.3% during the first quarter. Millennium Management LLC now owns 1,147,372 shares of the company’s stock valued at $19,551,000 after purchasing an additional 25,944 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of Broadstone Net Lease by 5.8% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,283,889 shares of the company’s stock valued at $21,877,000 after purchasing an additional 70,534 shares during the period. Finally, Jane Street Group LLC lifted its position in shares of Broadstone Net Lease by 292.3% during the first quarter. Jane Street Group LLC now owns 553,738 shares of the company’s stock worth $9,436,000 after purchasing an additional 412,604 shares in the last quarter. 89.07% of the stock is currently owned by institutional investors and hedge funds.

Broadstone Net Lease Stock Up 0.4% Shares of NYSE BNL opened at $21.20 on Tuesday. The stock’s 50 day moving average price is $21.44 and its two-hundred day moving average price is $20.28. Broadstone Net Lease, Inc. has a 52-week low of $17.16 and a 52-week high of $23.10. The stock has a market capitalization of $4.07 billion, a P/E ratio of 27.90 and a beta of 0.92.

Broadstone Net Lease (NYSE:BNL – Get Free Report) last issued its earnings results on Wednesday, July 29th. The company reported $0.21 EPS for the quarter, topping the consensus estimate of $0.19 by $0.02. The company had revenue of $122.31 million during the quarter, compared to analyst estimates of $121.63 million. Broadstone Net Lease had a return on equity of 4.83% and a net margin of 30.61%.Broadstone Net Lease has set its FY 2026 guidance at 1.550-1.570 EPS. On average, analysts anticipate that Broadstone Net Lease, Inc. will post 1.53 EPS for the current year. Broadstone Net Lease Announces Dividend The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Wednesday, September 30th will be issued a $0.2925 dividend. This represents a $1.17 dividend on an annualized basis and a yield of 5.5%. The ex-dividend date of this dividend is Wednesday, September 30th. Broadstone Net Lease’s payout ratio is currently 153.95%.

Insiders Place Their Bets In other Broadstone Net Lease news, Director Richard P. Imperiale bought 5,000 shares of the company’s stock in a transaction on Thursday, August 20th. The shares were bought at an average cost of $21.22 per share, with a total value of $106,100.00. Following the completion of the acquisition, the director owned 26,250 shares of the company’s stock, valued at approximately $557,025. This trade represents a 23.53% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.02% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades Several brokerages have recently weighed in on BNL. Truist Financial set a $22.00 target price on shares of Broadstone Net Lease in a research note on Monday, June 8th. Cantor Fitzgerald lifted their price target on shares of Broadstone Net Lease from $22.00 to $24.00 and gave the stock an “overweight” rating in a research note on Friday, July 31st. Weiss Ratings reiterated a “buy (b)” rating on shares of Broadstone Net Lease in a report on Friday, July 31st. BMO Capital Markets upped their price objective on shares of Broadstone Net Lease from $24.00 to $26.00 and gave the company an “outperform” rating in a research report on Friday, July 10th. Finally, KeyCorp upped their price objective on shares of Broadstone Net Lease from $20.00 to $24.00 and gave the company an “overweight” rating in a research report on Thursday, July 9th. Seven equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $22.78.

Read Our Latest Report on Broadstone Net Lease

Broadstone Net Lease Profile (Free Report)

Broadstone Net Lease, Inc (NYSE: BNL) is a publicly traded real estate investment trust focused on owning and operating single-tenant commercial properties under long-term net leases. The company specializes in acquiring properties that are leased to creditworthy tenants, allowing it to generate predictable, stable rental income while transferring most operating expenses and responsibilities to its lessees.

Broadstone Net Lease’s portfolio spans a variety of property types, including industrial facilities, distribution centers, manufacturing plants, life science and office buildings, and essential retail locations.

See Also Five stocks we like better than Broadstone Net Lease Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain Snowflake Could Be Headed for New Highs Despite Insider Selling MongoDB Is Surging—And the Next Catalyst Is Almost Here Want to see what other hedge funds are holding BNL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Broadstone Net Lease, Inc. (NYSE:BNL – Free Report).

Receive News & Ratings for Broadstone Net Lease Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Broadstone Net Lease and related companies with MarketBeat.com's FREE daily email newsletter.

Coinbase is cutting off trading for two tokens that have had a rough stretch. Badger DAO (BADGER) and Storj (STORJ) will both lose trading access on Coinbase starting September 28, 2026, at approximately 2 PM ET.

The announcement came on August 28, giving holders exactly one month to figure out their next move.

What the suspension actually means This is a trading suspension, not a full delisting. You can still reach your holdings and withdraw them. You just cannot place new trades. Coinbase transitioned both order books to limit-only mode immediately upon announcing the suspension, meaning market orders were shut off right away while limit orders and order matches remained temporarily active.

The suspension applies across Coinbase’s full product stack: coinbase.com’s Simple and Advanced Trade interfaces, Coinbase Exchange, and Coinbase Prime.

Coinbase frames these actions as routine housekeeping. The exchange periodically evaluates its listed assets against internal benchmarks covering liquidity and trading performance. This is not the first time Coinbase has done a sweep like this. Recent suspensions hit IOTX, IDEX, and LRC, sketching out a clear pattern: the exchange is tightening its roster, with lower-liquidity projects bearing the brunt.

Two different stories, one shared fate Badger DAO is a DeFi protocol that built its identity around Bitcoin yield products. Binance and Crypto.com both reduced support for BADGER in 2025, and those moves appear to have accelerated a slide in both liquidity and market attention.

Storj is a decentralized cloud storage network that distributes user data across a global network of independent operators rather than relying on centralized data centers. Storj Labs, the company behind the project, filed for Chapter 11 bankruptcy in July 2026, citing legacy liabilities. Chapter 11 is the reorganization variant of bankruptcy, not outright liquidation, and Storj Labs has indicated its decentralized storage network remains operational through the process.

The Coinbase suspension landing just two months after the bankruptcy filing is probably not a coincidence, though Coinbase has not cited the bankruptcy explicitly as a factor.

What holders should be thinking about The practical read for anyone holding BADGER or STORJ on Coinbase is straightforward: trading access ends September 28. Withdrawals remain available, so assets are not at risk of being locked. But the limit-only mode already in effect means price discovery is becoming thinner.

For STORJ, the backdrop of Storj Labs’ bankruptcy adds another layer of complexity. Equity holders in Storj Labs and STORJ token holders are technically different categories of stakeholder, but market psychology rarely draws that line carefully.

The broader pattern here is worth watching beyond just these two tokens. Coinbase’s recent string of suspensions points to an exchange actively curating its listing quality rather than chasing volume at all costs.

Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.

Bank of America Corp DE lifted its position in Grocery Outlet Holding Corp. (NASDAQ:GO – Free Report) by 31.3% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,083,541 shares of the company’s stock after acquiring an additional 258,292 shares during the period. Bank of America Corp DE owned 1.10% of Grocery Outlet worth $7,639,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. UBS Group AG lifted its holdings in shares of Grocery Outlet by 87.6% in the 4th quarter. UBS Group AG now owns 2,726,299 shares of the company’s stock valued at $27,536,000 after buying an additional 1,272,859 shares during the period. Vanguard Group Inc. grew its holdings in Grocery Outlet by 1.9% during the fourth quarter. Vanguard Group Inc. now owns 11,255,936 shares of the company’s stock worth $113,685,000 after acquiring an additional 213,325 shares during the period. CenterBook Partners LP grew its holdings in Grocery Outlet by 262.2% during the fourth quarter. CenterBook Partners LP now owns 645,159 shares of the company’s stock worth $6,516,000 after acquiring an additional 467,019 shares during the period. Clearbridge Investments LLC raised its position in Grocery Outlet by 6.6% during the fourth quarter. Clearbridge Investments LLC now owns 2,816,721 shares of the company’s stock valued at $28,449,000 after acquiring an additional 173,308 shares in the last quarter. Finally, Heartland Advisors Inc. raised its position in Grocery Outlet by 146.3% during the fourth quarter. Heartland Advisors Inc. now owns 682,650 shares of the company’s stock valued at $6,895,000 after acquiring an additional 405,500 shares in the last quarter. Hedge funds and other institutional investors own 99.87% of the company’s stock.

Wall Street Analysts Forecast Growth Several research firms recently issued reports on GO. Wells Fargo & Company boosted their target price on shares of Grocery Outlet from $9.00 to $11.00 and gave the company an “equal weight” rating in a research note on Thursday, August 13th. Morgan Stanley raised their price target on shares of Grocery Outlet from $7.00 to $11.00 and gave the company an “equal weight” rating in a research report on Thursday, August 13th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $9.00 price objective on shares of Grocery Outlet in a report on Thursday, August 13th. UBS Group upped their price objective on shares of Grocery Outlet from $10.00 to $11.50 and gave the stock a “neutral” rating in a research report on Monday, August 17th. Finally, Weiss Ratings raised shares of Grocery Outlet from a “sell (d-)” rating to a “sell (d)” rating in a research note on Thursday, August 13th. Twelve investment analysts have rated the stock with a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Reduce” and a consensus target price of $10.59.

View Our Latest Research Report on Grocery Outlet Insider Activity In other Grocery Outlet news, insider Paul Blaine Miller acquired 8,000 shares of the stock in a transaction dated Thursday, August 20th. The stock was acquired at an average price of $10.90 per share, with a total value of $87,200.00. Following the completion of the purchase, the insider owned 72,171 shares in the company, valued at $786,663.90. This trade represents a 12.47% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders have bought a total of 23,000 shares of company stock worth $228,400 over the last 90 days. 5.60% of the stock is currently owned by corporate insiders.

Grocery Outlet Price Performance Grocery Outlet stock opened at $12.12 on Wednesday. Grocery Outlet Holding Corp. has a 12-month low of $5.66 and a 12-month high of $19.23. The stock has a market cap of $1.20 billion, a P/E ratio of -3.13, a PEG ratio of 8.49 and a beta of 0.65. The company has a 50-day moving average price of $9.99 and a 200 day moving average price of $8.74. The company has a current ratio of 1.29, a quick ratio of 0.30 and a debt-to-equity ratio of 0.60.

Grocery Outlet (NASDAQ:GO – Get Free Report) last posted its earnings results on Wednesday, August 12th. The company reported $0.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.13 by $0.07. The company had revenue of $1.19 billion during the quarter, compared to analysts’ expectations of $1.17 billion. Grocery Outlet had a positive return on equity of 5.84% and a negative net margin of 8.04%.The firm’s quarterly revenue was up 1.1% compared to the same quarter last year. During the same quarter last year, the firm earned $0.23 earnings per share. Sell-side analysts anticipate that Grocery Outlet Holding Corp. will post 0.42 earnings per share for the current year.

Grocery Outlet Profile (Free Report)

Grocery Outlet Holding Corp. (NASDAQ: GO) is a specialty discount retailer that offers consumers deeply discounted groceries by purchasing excess inventory, closeouts, and overstocks from manufacturers and distributors. Headquartered in Emeryville, California, the company operates two primary banners—Grocery Outlet and Fresh2Go—with a combined footprint of more than 400 stores. Its product assortment spans fresh produce, meat, dairy, bakery items, household staples, natural and organic offerings, and select specialty products, all sold at significant markdowns compared to conventional supermarkets.

The company’s unique buying model enables it to source inventory through opportunistic purchases of surplus freight, discontinued items, and closeout deals, which it then passes on as savings to its customers.

Featured Stories Five stocks we like better than Grocery Outlet Pathward’s Credit Scare Tests Its Comeback Story Wiring the AI Boom: Rumble’s $13.7B Pivot StoneX: Too Far Too Fast? DICK’s Sporting Goods Faces Pain Now for a Bigger Prize

Receive News & Ratings for Grocery Outlet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grocery Outlet and related companies with MarketBeat.com's FREE daily email newsletter.